WO2024246169A1 - Plant treatment method - Google Patents
Plant treatment method Download PDFInfo
- Publication number
- WO2024246169A1 WO2024246169A1 PCT/EP2024/064846 EP2024064846W WO2024246169A1 WO 2024246169 A1 WO2024246169 A1 WO 2024246169A1 EP 2024064846 W EP2024064846 W EP 2024064846W WO 2024246169 A1 WO2024246169 A1 WO 2024246169A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- mangostin
- phosphonates
- chitosan
- extract
- mangostana
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01P—BIOCIDAL, PEST REPELLANT, PEST ATTRACTANT OR PLANT GROWTH REGULATORY ACTIVITY OF CHEMICAL COMPOUNDS OR PREPARATIONS
- A01P3/00—Fungicides
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
- A01N43/02—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one or more oxygen or sulfur atoms as the only ring hetero atoms
- A01N43/04—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one or more oxygen or sulfur atoms as the only ring hetero atoms with one hetero atom
- A01N43/14—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one or more oxygen or sulfur atoms as the only ring hetero atoms with one hetero atom six-membered rings
- A01N43/16—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one or more oxygen or sulfur atoms as the only ring hetero atoms with one hetero atom six-membered rings with oxygen as the ring hetero atom
Definitions
- the invention relates to the field of agriculture and to a treatment of plants based on an antifungal compound, in particular phosphonate compounds (salts of phosphorous acid) or chitosan in which the action of this compound is improved by co-administration, in particular of an extract of Garcinia mangostana.
- an antifungal compound in particular phosphonate compounds (salts of phosphorous acid) or chitosan in which the action of this compound is improved by co-administration, in particular of an extract of Garcinia mangostana.
- Plants are subject to many fungal diseases that can cause significant yield and therefore economic losses.
- phosphonates are salts of phosphorous acid, derived from phosphate rocks. Phosphonates have fungicidal properties. Many trials in different countries have shown the effectiveness of phosphonates against many cryptogamic diseases: Downy mildew of grapevines, Phytophtora of fruit trees, Pythium, etc. The use of phosphonates (potassium phosphonate, disodium phosphonate) constitutes a particularly interesting alternative to copper given their effectiveness. Biocontrol phosphonates have a dual activity: fungicide and stimulator of plant defenses.
- Biocontrol phosphonates are used preventively. In case of low pressure, the use of phosphonates alone is possible but it is however recommended to associate them with a partner fungicide of contact at a reduced dose, in order to complete the efficacy on leaves and to ensure an optimal protection of the plants.
- the management of the rates between two applications is just as important as with any other fungicide, in particular in case of heavy precipitation.
- phosphonate sprays systematically result in residues of phosphorous acid, in particular in wines. These residues are lower than the MRLs and are not dangerous for the consumer. In addition, these products are prohibited in organic farming.
- Phosphonates in particular potassium phosphonates
- concentrations that can vary from 2.5 g/L to 30 g/L on average.
- Phosphonates in particular potassium phosphonates
- Phosphonates are authorised for marketing in France, in particular for the following applications, with maximum recommended doses and number of applications (when phosphonates are used alone, they are at a concentration of 720-755 g/L):
- Solanaceae including tomatoes and eggplants: mildew(s), 2.5-4 L/ha, 3-5 applications
- Pome fruits (apple trees, pear trees, quince trees, etc.): scab, 1.9-2.5 L/ha, 6 applications
- Vine downy mildew(s) 2.5-4 L/ha 2-5 applications; black rot (Guignardia bidwellii) 4 L/ha 4 applications; Excoriosis (Phomopsis viticola) 3 L/ha
- Fruit crops such as blueberry, currant, gooseberry, peach and nectarine: Fungi (Pythiaceae, including Phytophthora spp), 2.5-4 L/ha 3 applications (aerial parts); 10 L/ha 3 applications
- Citrus (orange, lemon, grapefruit, mandarin, clementine and lime): Phytophthora citrophthora; collar canker (Phytophthora cactorurrf) 5-8.75 L/ha 1-2 applications; Fungi (Pythiaceae) 4-6 L/ha 3-4 applications Wheat: Septoria; 4 L/ha 2 applications (aerial parts)
- Chitosan (or chitosan) is a natural polymer obtained by the partial deacetylation of chitin that is now widely used in many fields of application. Given its biodegradable and non-toxic nature, chitosan represents a promising alternative to plant protection products from the chemical industry. It has strong potential in the field of combating biotic stress where it constitutes an effective treatment against certain diseases. It has two modes of action that come on the one hand from its bacterio- and fungistatic properties (antimicrobial activity) and on the other hand from its ability to induce the natural defenses of plants (SDP). Indeed, thanks to its cationic character, chitosan polymers will interact with the cell membranes of negatively charged pathogens which will alter membrane permeability. Through an elicitor mechanism, chitosan will also stimulate the natural defenses of plants in response to a broad spectrum of phytopathogens. Used alone, chitosan generally does not achieve a level of protection equivalent to a synthetic fungicide reference.
- Chitosan is authorised for marketing in Europe, in particular as chitosan hydrochloride, for the protection of various plants against fungal or bacterial infections. Chitosan of fungal origin is also authorised. Chitosan acetate (obtained with acetic acid rather than hydrochloric acid) may also be considered.
- Examples include protection against fungal infections of olive trees, vines (Vitis vinifera), lawns, meadows, ryegrass, sugar beets, cereals, potatoes, vegetables, berries and small fruits (blackcurrants, strawberries, raspberries, blueberries, etc.), and bulbous ornamental plants.
- Table 1 provides a list of plants and bacterial or fungal pathogens that may be treated with phosphonates or chitosan.
- phosphonates are approved against a large number of fungal diseases and bacterial diseases, for perennial crops (vines, fruit crops), market gardens (crops belonging to various botanical families), large-scale crops (control of potato blight, and against some fungal diseases of wheat and rye (in particular septoria due to Steptoria sp. In particular Septoria tritici or Septoria nodorum).
- Phosphonates can also be used against various fungal diseases affecting perfume, aromatic and medicinal plants (PPAM), ornamental species and seed crops, or which develop on wood wounds.
- Chitosan can also be used against a large number of fungal diseases and bacterial diseases, for perennial crops (vines, fruit crops), market gardens (crops belonging to various botanical families), large-scale crops (fight against potato blight, and against some fungal diseases of wheat and rye (notably fusarium) transmitted by seeds.
- apple scab caused by Venturia inaequalis, for which apple orchards receive an average of 23 fungicide/bactericide treatments per year (15 to 29 depending on the region), of which nearly three-quarters target scab.
- Phosphonate-based treatments could also control Nectria galligena, which causes European canker.
- Potato blight caused by Phytophthora infestans causes yield losses that can lead to total destruction of the plot, or quality losses in the event of late attacks. On average, 10 to 12 treatments are carried out, or up to 15 or 20 in areas at high risk of blight. P. infestans can also cause significant damage to tomatoes (also from the Solanaceae family).
- Beet leaf spot is a leaf disease caused by Cercospora beticola, which can cause significant damage if attacks occur early or in irrigated areas.
- Black spot disease is caused by Alternaria brassicicola on a wide range of hosts, particularly in the genus Brassica, including a number of economically important crops such as cabbage, Chinese cabbage, cauliflower, oilseeds, broccoli and canola.
- Lettuce downy mildew is caused by Bremia lactucae and can cause death of young seedlings.
- Septoria leaf spot of wheat is a fungal disease caused mainly by Septoria tritici and Septoria nodorum, which affects wheat and other species of the genus Triticum. It can cause yield losses of more than 40%.
- Alternaria solani can cause a disease called alternaria leaf spot or alternaria blight in plants of the Solanaceae family, including tomatoes and potatoes, but also peppers and eggplants, which manifests itself as circular black spots, in which concentric circles are visible, on the leaves of the plants, and can lead to defoliation.
- the invention relates to a method for treating a plant, comprising the simultaneous, staggered or separate application in time of (I) y-mangostin and (II) a phytosanitary product chosen from (i) phosphonates, in particular potassium phosphonates, and (ii) chitosan. It is preferred when compounds (I) and (II) are applied to obtain a synergistic effect (thus making it possible to obtain an effect greater than the sum of the individual effects).
- the desired effect is in particular a fertilizing effect to improve plant growth or leaf growth, or an antifungal or antibacterial effect to combat bacteriosis or fungal diseases.
- y-mangostin can be provided via a Garcinia mangostana extract containing y-mangostin, in particular between 2 and 15% (by weight) of y-mangostin.
- This extract may result from the maceration of pericarps of G. mangostana in a polar solvent, preferably in ethanol. It is preferred that y-mangostin and compound (II) are applied simultaneously.
- ⁇ -Mangostin and compound (II) may be applied to prevent or control bacterial or fungal diseases, or as a fertilizing agent to improve plant growth or leaf growth.
- Compound (II) may be phosphonates, in particular potassium phosphonates.
- Compound (II) may be chitosan, in particular chitosan hydrochloride.
- ⁇ -Mangostin is preferably applied at a rate of between 1 and 40 g/ha, preferably between 1 and 8 g/ha
- phosphonates are preferably applied at a quantity of between 250 and 4000 g/ha
- chitosan is preferably applied at a quantity of between 250 and 4000 g/ha.
- a composition comprising (I) y-mangostin and (II) a phytosanitary product selected from (i) phosphonates, in particular potassium phosphonates, and (ii) chitosan, compounds (I) and (II) preferably in doses and a ratio making it possible to obtain a synergistic effect, the use of such a composition as a fertilizing composition, or a phytosanitary composition, and/or for improving the growth and/or development and/or productivity of plants and/or defense against plant pathogens are also described.
- the invention relates to a method for treating plants, in which phosphonates, in particular potassium phosphonates, and y-mangostin, in particular contained in an extract of Garcinia mangostana, are combined.
- the treatment applied to the plants may have a phytosanitary and/or growth-stimulating effect. It may also be used as a fertilizer, fertilizer or biostimulant.
- the two compounds are advantageously added in conditions and proportions making it possible to obtain a synergistic effect (the examples and the information in the application allow a person skilled in the art to determine the doses making it possible to observe a synergy).
- the invention also relates to a phytosanitary composition
- a phytosanitary composition comprising phosphonates (ll)(i), in particular potassium, and y-mangostin (I), in particular contained in an extract of Garcinia mangostana, in particular when the extract contains y-mangostin.
- This composition contains the compounds (ll)(i) and (I) in proportions and amounts making it possible to obtain a synergistic effect during application.
- this method and the relative compositions make it possible to improve the effectiveness of phytosanitary products based on phosphonates, by reducing the doses of phosphonates, while maintaining the effect of preventing the appearance or treatment of fungal diseases of plants, for example downy mildew of grapevines, alternaria of cruciferous plants, downy mildew of lettuce or even septoria of wheat.
- the invention also relates to a method for treating plants, in which chitosan (ll)(ii), in particular chitosan hydrochloride and y-mangostin, in particular contained in an extract of Garcinia mangostana, are combined.
- the treatment applied to the plants can have a phytosanitary and/or growth-stimulating effect. It can also be used as a fertilizer.
- the invention also relates to a phytosanitary composition
- a phytosanitary composition comprising chitosan (ll)(ii), in particular chitosan hydrochloride, and y-mangostin (I), in particular contained in an extract of Garcinia mangostana.
- This composition contains compounds (ll)(ii) and (I) in proportions and quantities enabling a synergistic effect to be obtained upon application.
- this method and the relative compositions make it possible to improve the effectiveness of chitosan-based phytosanitary products, by potentially reducing the doses of chitosan, while maintaining the effect of preventing the appearance or treating fungal diseases of plants, for example downy mildew of grapevines, alternaria of cruciferous plants or even downy mildew of lettuce.
- chitosan can be applied in combination with y-mangostin, which can potentiate the effect of chitosan, via a synergistic effect.
- plant diseases can be effectively combated while drastically reducing the quantities of chitosan applied compared to current practices.
- WO 2023/099609 describes a method for preventing, controlling or treating a fungal infection on a plant organ comprising applying to said plant organ a non-fungicidal amount or a potentiating amount of a composition comprising a potentiating agent of a plant defense molecule, in combination with a phytopharmaceutical vehicle.
- the molecules described in this document include molecules of general formula (I).
- Gopalakrishnan et al J Nat Prod. 1997 May;60(5):519-24) described the isolation of several xanthones from G. mangostana, including y-mangostin (compound 5), and the analysis of their antifungal effect.
- Tables 3-5 show that y-mangostin is the most potent compound.
- Azman et al (Food Control, (2022) 141, 109189) describe films containing chitosan and mangosteen extracts.
- the invention thus relates to a method of treating a plant, comprising the simultaneous, staggered or separate application in time of (I) y-mangostin and (II) a phytosanitary product chosen from (i) phosphonates, in particular potassium phosphonates, and (ii) chitosan, compounds (I) and (II) being applied to obtain a synergistic effect
- Gamma mangostin (y-mangostin) has the formula (I).
- alpha-mangostin has the same R1-R6 and R8 groups as gamma-mangostin, but an -O-CH3 group in position R7.
- This molecule is present in the mangosteen shell (Garcinia mangostana). We can thus use an extract of Garcinia mangostana to bring this molecule into the composition to be applied to plants, with phosphonates.
- the G. mangostana extract contains y-mangostin and a-mangostin.
- the ratio of Y-mangostin to a-mangostin is between 1:4 and 1:9, or between 1:6 and 1:8.
- an extract of Garcinia mangostana is used, preferably selected from the leaf, bark or pericarp extract of Garcinia mangostana.
- the extract is a pericarp extract of Garcinia mangostana.
- this extract is an aqueous extract, a hydroalcoholic extract, an ethanolic extract, a methanolic extract, an ethyl acetate extract or a supercritical CO2 extract.
- these extracts can in particular be obtained by maceration of pericarps of Garcinia mangostana in a solvent (in particular a polar solvent), as described.
- the extract is obtained with a mixture of ethyl acetate and ethanol, typically in a volumetric ratio of ethyl acetate:ethanol ranging from 60:40 to 90:10, from 70:30 to 80:20, from 75:25 to 80:20.
- the extract is obtained with a mixture of ethyl acetate and ethanol, in an ethyl acetate:ethanol volumetric ratio of about 75:25, about 76:24, about 77:23, about 78:22, about 79:21, or about 80:20.
- ethanol is used only as a solvent.
- the maceration is carried out using water and ethanol as solvents. In one embodiment, the maceration is carried out using supercritical CO2 and ethanol as solvents.
- the plant:solvent ratio is between 1:2 and 1:10 (% weight/weight), preferably between 1:4 and 1:6.
- Extracts can be obtained by ultrasound or microwave-assisted extraction methods.
- a crude extract of the plant or a fractionated portion thereof may be used, including using any method known in the art such as chromatography, to fractionate a crude extract, such as liquid-liquid extraction/fractionation and/or adsorption/absorption chromatography.
- the fractionated portions of the crude extract may comprise y-mangostin at different concentrations.
- the crude extract of Garcinia mangostana pericarp may further comprise other xanthones, such as 1,3,5-trihydroxy-4-prenylxanthone, 1,3,5-trihydroxy-2-prenylxanthone.
- the crude extract of Garcinia mangostana pericarp may further comprise xanthones, such as ⁇ -mangostin.
- the crude extract of Garcinia mangostana pericarp may be used at a concentration where all of its constituents are in an in vitro amount that is not directly fungicidal, such as less than 200 mg/L, less than 150 mg/L or less than 100 mg/mL.
- Compositions containing up to 1 g/L can also be used (used to provide a dose of approximately 200 g/Ha, or a volume of 200 L/Ha).
- a final extract of Garcinia mangostana comprising from 3 to 12%, or from 3 to 10% w/w of y-mangostin on a dry weight basis relative to the dry weight of the final extract can be obtained.
- 100 mg of final extract of G. mangostana comprises about 6 mg of y-mangostin.
- the extract of G. mangostana may also contain alpha-mangostin.
- a person skilled in the art will be able to adapt these non-fungicidal quantities if a fraction rich in y-mangostin or poor in y-mangostin is used instead of the crude extract of Garcinia mangostana pericarp, in particular obtained by extraction with a polar solvent.
- the method according to the invention makes it possible to reduce the quantities of phosphonates or chitosan used to combat pathogens.
- the dose of phosphonates or chitosan can be reduced, i.e. a lower dose can be used (generally divided by at least 2) compared to the dose used in practice or that which allows a maximum effect to be obtained when phosphonates or chitosan are used alone.
- doses can thus be used which do not a priori allow the pathogen to be combated in vivo or the growth of the pathogen to be prevented in vitro. If the doses are not reduced, the effect obtained will be better than when phosphonates or chitosan are used alone.
- the quantity of phosphonates or chitosan applied per hectare depends essentially on the type of plants to be protected, rainfall, and pest pressure.
- the phosphonates and y-mangostin, particularly in an extract of G. mangostana are applied simultaneously.
- a composition comprising both the phosphonates and y-mangostin is prepared.
- the phosphonates and y-mangostin are administered simultaneously or successively, by application to the plants (in particular spraying, spreading, watering) or any other means making it possible to provide the phosphonates and y-mangostin to the infected or susceptible place (site). It is possible to start by applying the phosphonates then the y-mangostin, or to provide first the y-mangostin then the phosphonates.
- the phosphonates and ⁇ -mangostin are mixed in the same container or placed in two separate containers.
- Phosphonates are generally applied at a rate of between 250 and 4000 g/ha (grams per hectare), preferably between 500 and 1000 g/ha, preferably between 600 and 900 g/ha, preferably between 700 and 800 g/ha. Due to the synergy, it is also possible to consider reducing the doses applied.
- the phosphonates are potassium phosphonates. In another embodiment, the phosphonates are disodium phosphonates.
- chitosan and y-mangostin particularly in an extract of G. mangostana are applied simultaneously.
- a composition comprising both chitosan and y-mangostin is prepared.
- the chitosan and ⁇ -mangostin are administered simultaneously or successively, by application to the plants (in particular spraying, spreading, watering) or any other means making it possible to provide the chitosan and ⁇ -mangostin to the infected or susceptible place (site). It is possible to start by applying the chitosan then the ⁇ -mangostin, or to provide first the ⁇ -mangostin then the chitosan.
- the chitosan and the ⁇ -mangostin are mixed in the same container or placed in two separate containers.
- the amount of chitosan applied per hectare is between 10 and 1000 g/ha, preferably between 20 and 90 g/ha, preferentially between 30 and 80 g/ha, more preferentially between 40 and 160 g/ha per administration.
- higher doses can be applied depending on the nature and quality of the chitosan. Due to the synergy, it is also possible to consider reducing the doses applied.
- chitosan In crop protection, chitosan is usually found in the form of chitosan hydrochloride.
- chitosan of the original type is also available.
- Chitosan acetate salt can also be made with acetic acid.
- the amount of y-mangostin supplied per hectare according to the invention is between 1 and 40 g/ha, preferably between 1 and 15 g/ha, preferentially between 1.5 and 10 g/ha, more preferentially between 4 and 8 g per hectare.
- the composition is in liquid form. It is administered by spraying or watering.
- the composition is in a form allowing the coating or film-coating of seeds: this is particularly suitable for the control or prevention of root fusarium diseases affecting cereals.
- phosphonates in particular potassium or chitosan, and y-mangostin, in particular as an extract of G. mangostana
- these elements can be used to prevent or combat the diseases mentioned in Table 1, for the plants considered.
- emphasis can be placed on the prevention or control of apple scab (Venturia inaequalis), mildew in particular of vines, lettuce or potatoes, Botrytis infections in particular on vines and tomatoes, Fusarium infections in particular on cereals (wheat and barley), cereal septoria, Septoria sp.
- Phosphonates and chitosan can also be used in fertilizers. Indeed, they help to strengthen the vigor of plants, as elicitors of natural defenses.
- phosphonates or chitosan and y-mangostin can be used as fertilizers or fertilizing agents to improve plant growth or foliar growth.
- the invention also relates to a composition for application to plants comprising phosphonates, in particular potassium phosphonates, and y-mangostin, in particular as an extract of G. mangostana.
- the invention also relates to a composition for application to plants comprising chitosan, in particular chitosan hydrochloride, and y-mangostin, in particular as an extract of G. mangostana.
- compositions can be used as a fertilizing agent, or a phytosanitary agent, in particular depending on the concentrations of the two elements that are present. They therefore have advantages for the growth and/or nutrition and/or health of plants.
- the concentrations of each of the compounds are determined by the person skilled in the art, and can be increased or decreased, depending on the quantity of composition that one wishes to apply per hectare, and the dilution of the “mother” composition before application.
- the quantities can be low, or high.
- Phosphonates or chitosan are advantageously mixed with an extract of G. mangostana, as seen above, which provides y-mangostin.
- a "mother” composition is generally made to be diluted (generally 1:100 or 0.5:100 (v:v)) before application to plants.
- the quantities applied are preferably those mentioned above.
- the composition is generally applied after appropriate dilution, to the leaves or fruits of the plant (foliar or fruit application), by spraying. However, the composition can be applied after appropriate dilution, at the base of the plant.
- composition can be in the form of a suspension, emulsion or dispersion in a preferably aqueous phase, but also in the form of a powder or granules or tablets. In these latter embodiments, water is added before administration, to obtain the adequate quantities of phosphonates or chitosan and y-mangostin.
- the composition may also contain trace elements (zinc, boron, manganese, silicon, iron, etc.) to provide the elements useful for plant growth and have a fertilizing effect.
- It also preferably contains co-formulants (chosen in particular from texturizing agents, wetting agents, surfactants, suspenders, emulsifiers, preservatives, etc.) adapted according to the intended application (administration by spraying on the leaves, at the base of the plant, in the watering water, etc.).
- co-formulants chosen in particular from texturizing agents, wetting agents, surfactants, suspenders, emulsifiers, preservatives, etc.
- the invention also relates to a method for manufacturing a composition as described comprising the simultaneous or successive incorporation of at least phosphonates, in particular potassium phosphonates, or chitosan, in particular chitosan hydrochloride and ⁇ -mangostin with co-formulating agents. These elements can then be mixed to obtain a suspension, an emulsion or a dispersion in a preferably aqueous phase.
- co-formulating agents include surfactants (surfactants), to reduce the surface tension between liquids and surfaces and improve the dispersion and adhesion of active agents (in particular alkylphenol ethoxylates, polysorbates), adjuvants that increase the penetration of active agents into plants (mineral oils, vegetable oils, wetting agents), suspending agents to maintain solid particles in suspension in liquid formulations (bentonite, colloidal silica), stabilizers to prevent decomposition of active agents by environmental factors such as light, heat or oxygen (antioxidants, UV absorbers), solvents allowing the dissolution of active agents to create a homogeneous formulation and facilitate application (organic solvents such as xylene, acetone, ethanol), sequestration agents to bind metal ions that could otherwise inactivate the active agents (EDTA (ethylenediaminetetraacetic acid), citric acid), polymers or gelling agents, penetrating agents (alcohol ethoxylates, sulfosuccinates), buffers
- the invention also relates to the use of the composition as described for improving the growth and/or development and/or productivity of plants.
- the invention also relates to the use of the composition as as described to control or prevent a plant infection, particularly a bacterial or fungal infection.
- the invention also relates to the composition as described, or to its use, as a fertilizer product (for improving the growth and/or development and productivity of plants).
- the invention also relates to the composition as described, or to its use, as a phytosanitary product (for its antifungal effect for combating or preventing a plant infection, in particular a bacterial or fungal infection).
- Efficacy Indicator for quantifying the effect of a plant protection product on reducing damage (severity or incidence) caused by a plant disease. This is calculated using the Abbott formula presented below:
- Synergy Corresponds to the interaction between at least two products whose combined effects are greater than the sum of their own effects (effect of the type “one plus one is greater than two”).
- R ratio Indicator used to describe the relationship between two plant protection products with regard to the effectiveness obtained by their combined application. This relationship can be of three types:
- the efficacy obtained by co-application is lower than the sum of the efficacies of the two products applied alone (type 1+1 ⁇ 2);
- the R ratio is calculated by dividing the observed efficiency (E O bs) by the combination of products by the theoretical efficiency (E ⁇ éo):
- the ratio R is a tool for assessing the level of synergy between two products, with synergy being all the more important as R is large.
- the crushed Garcinia mangostana pericarps are extracted twice with ethanol as solvent, with a plant/solvent ratio ranging from 1:4 to 1:8 (% w/w) for each extraction, at room temperature.
- the average extraction yield is between 6 and 15%, i.e. between 6 and 15 g of Garcinia mangostana pericarp extract are obtained using 100 g of Garcinia mangostana pericarps as raw material.
- the extract obtained is composed of y-mangostin in a proportion ranging from 3 to 12% (% w/w), and a-mangostin in a proportion ranging from 20 to 50% (% w/w).
- crushed Garcinia mangostana pericarps are extracted with supercritical CO2 as solvent and ethanol as co-solvent (30%), under suitable conditions of temperature, pressure and flow rate of the solvent and co-solvent.
- the average extraction yield is between 6 and 15%, i.e. between 6 and 15 g of Garcinia mangostana pericarp extract are obtained using 100 g of Garcinia mangostana pericarp as raw material.
- the extract obtained is composed of y-mangostin in a proportion ranging from 3 to 12% (% w/w), and a-mangostin in a proportion ranging from 20 to 50% (% w/w).
- the crushed Garcinia mangostana pericarps are extracted with a water:ethanol mixture (70:30 by volume) as solvent, with a plant/solvent ratio ranging from 1:4 to 1:16 (% w/w) for each extraction, at room temperature.
- the average extraction yield is between 6 and 15%, i.e. between 6 and 15 g of Garcinia mangostana pericarp extract are obtained using 100 g of Garcinia mangostana pericarps as raw material.
- the extract obtained is composed of y-mangostin in a proportion ranging from 3 to 12% (% w/w), and a-mangostin in a proportion ranging from 20 to 50% (% w/w).
- Example 3 Synergy between an extract of Garcinia mangostana (MCE or GME) and potassium phosphonates - in planta tests on wheat septoria (Septoria tritici).
- Potassium phosphonates were used at a dose of 151 mg/L, alone and in combination with GME at 247.5 mg/L.
- Potassium phosphonates were used at a dose of 151 mg/L, alone and in combination with GME at 247.5 mg/L.
- Table 3 In planta potato blight trials.
- a synergy is observed in in planta conditions with a significant gain in protection compared to products used alone.
- Example 6 Synergy between a G. mangostana extract (GME) and potassium phosphonates - in vitro tests on Plasmopara viticola (vine mildew) Using GME (1.5 and 2 mg/L) and LBG 01 F34 (potassium phosphonates, De Sangosse, France) at 0.0015% and 0.003%, a synergy ratio between 1.3 and 2.0 was observed.
- GME G. mangostana extract
- LBG 01 F34 potassium phosphonates
- Example 1 Synergy between an extract of Garcinia mangostana and chitosan hydrochloride - in vitro tests on Alternaria brassicicola (alternaria of cabbage),
- each dose alone and in combination was applied to a suspension of Alternaria brassicicola for a period of 4 hours. After 4 hours, the suspension is diluted in cascade until reaching a concentration of 1*10 3 conidia per mL of PDB (Potato Dextrose Broth).
- PDB Pantotato Dextrose Broth
- the different modalities are then distributed in a 96-well plate placed in a nephelometer at 25°C for 338 cycles of 600 s, or a total of approximately 56 hours, to monitor the growth of the pathogen subjected to the different conditions.
- the data are then analyzed using Omega data analysis software to obtain areas under the curve and calculate inhibition percentages presented in Table 4.
- GME is used at 247.5 mg/L.
- a synergy is thus observed in in planta conditions with a significant gain in protection compared to products used alone, including chitosan at a reduced dose.
- Table 6 Tests on Bremia lactucae in planta.
- the above trials show an effect of the combined use of an extract of G. mangostana (containing y-mangostin) and phosphonates on various pathogens, according to different in planta protocols. These trials have demonstrated a synergistic effect between GME and potassium phosphonates.
- the above trials also show an effect of the combined use of an extract of G. mangostana (containing y-mangostin) and chitosan on various pathogens, according to different in planta, in vitro protocols. These trials have demonstrated a synergistic effect between GME and chitosan.
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Wood Science & Technology (AREA)
- Environmental Sciences (AREA)
- Pest Control & Pesticides (AREA)
- Plant Pathology (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Dentistry (AREA)
- Agronomy & Crop Science (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Abstract
Description
MÉTHODE DE TRAITEMENT DE PLANTES METHOD OF TREATMENT OF PLANTS
L’invention se rapporte au domaine de l’agriculture et à un traitement de plantes à base d’un composé antifongique, notamment des composés phosphonates (sels de l'acide phosphoreux) ou du chitosan dans laquelle l’action de ce composé est améliorée par co-administration, notamment d’un extrait de Garcinia mangostana. The invention relates to the field of agriculture and to a treatment of plants based on an antifungal compound, in particular phosphonate compounds (salts of phosphorous acid) or chitosan in which the action of this compound is improved by co-administration, in particular of an extract of Garcinia mangostana.
Les plantes sont sujettes à de nombreuses maladies fongiques pouvant entrainer des pertes de rendement, et donc économiques, importantes. Plants are subject to many fungal diseases that can cause significant yield and therefore economic losses.
Ainsi que mentionné sur le site wiki.tripleperformance.fr (Utiliser_des_phosphonates_dans_la_lutte_contre_le_mildiou), les phosphonates sont des sels de l'acide phosphoreux, issus de roches phosphatées. Les phosphonates possèdent des propriétés fongicides. De nombreux essais dans différents pays ont montré l’efficacité des phosphonates contre de nombreuses maladies cryptogamiques : Mildiou de la vigne, Phytophtora des arbres fruitiers, Pythium, etc... L’utilisation de phosphonates (phosphonate de potassium, disodium phosphonate) constitue une alternative au cuivre particulièrement intéressante compte tenu de leur efficacité. Les phosphonates de biocontrôle possèdent une double activité : fongicide et stimulateur de défenses des plantes. Ils agissent ainsi directement sur le pathogène (effet fongicide principal) mais aussi indirectement en stimulant les défenses des plantes en activant notamment des phyto-alexines. Les phosphonates de biocontrôle s’utilisent de façon préventive. En cas de faible pression, l’usage seul de phosphonates est possible mais il est toutefois recommandé de les associer avec un fongicide partenaire de contact à dose réduite, afin de compléter l’efficacité sur feuilles et d’assurer une protection optimale des plantes. La gestion des cadences entre deux applications est tout aussi importante qu’avec n’importe quel autre fongicide, notamment en cas de forte précipitations. Cependant, les pulvérisations de phosphonate entraînent systématiquement des résidus d’acide phosphoreux, notamment dans les vins. Ces résidus sont inférieurs aux LMR et sans danger pour le consommateur. De plus, ces produits sont interdits en agriculture biologique. Ces produits sont couramment utilisés à des doses aboutissant à des quantités de phosphonates de 1 ,5 à 3 kg par hectare, représentant des concentrations pouvant varier de 2,5 g/L à 30 g/L en moyenne. Les phosphonates (en particulier les phosphonates de potassium) sont autorisés à la commercialisation en France, notamment pour les applications suivantes, avec des doses et nombre d’applications maximales préconisées (lorsque que les phosphonates sont utilisés seuls, ils sont à une concentration de 720-755 g/L) : As mentioned on the site wiki.tripleperformance.fr (Using_phosphonates_in_the_fight_against_mildiou), phosphonates are salts of phosphorous acid, derived from phosphate rocks. Phosphonates have fungicidal properties. Many trials in different countries have shown the effectiveness of phosphonates against many cryptogamic diseases: Downy mildew of grapevines, Phytophtora of fruit trees, Pythium, etc. The use of phosphonates (potassium phosphonate, disodium phosphonate) constitutes a particularly interesting alternative to copper given their effectiveness. Biocontrol phosphonates have a dual activity: fungicide and stimulator of plant defenses. They thus act directly on the pathogen (main fungicidal effect) but also indirectly by stimulating the defenses of plants by activating phyto-alexins in particular. Biocontrol phosphonates are used preventively. In case of low pressure, the use of phosphonates alone is possible but it is however recommended to associate them with a partner fungicide of contact at a reduced dose, in order to complete the efficacy on leaves and to ensure an optimal protection of the plants. The management of the rates between two applications is just as important as with any other fungicide, in particular in case of heavy precipitation. However, phosphonate sprays systematically result in residues of phosphorous acid, in particular in wines. These residues are lower than the MRLs and are not dangerous for the consumer. In addition, these products are prohibited in organic farming. These products are commonly used at doses resulting in quantities of phosphonates of 1.5 to 3 kg per hectare, representing concentrations that can vary from 2.5 g/L to 30 g/L on average. Phosphonates (in particular potassium phosphonates) are authorised for marketing in France, in particular for the following applications, with maximum recommended doses and number of applications (when phosphonates are used alone, they are at a concentration of 720-755 g/L):
Solanacées (dont tomates et aubergines) : mildiou(s), 2,5-4 L/ha, 3-5 applications Solanaceae (including tomatoes and eggplants): mildew(s), 2.5-4 L/ha, 3-5 applications
Fruits à pépins (pommiers, poiriers, cognaciers...) : tavelure, 1,9-2, 5 L/ha, 6 applications Pome fruits (apple trees, pear trees, quince trees, etc.): scab, 1.9-2.5 L/ha, 6 applications
Chicorées, 3,5 L/ha 4 applications Chicory, 3.5 L/ha 4 applications
Cucurbitacées à peau comestible, 3,5 L/ha 5 applicationsCucurbits with edible skin, 3.5 L/ha 5 applications
Cucurbitacées à peau non comestible, 3,5 L/ha 3 applicationsCucurbits with inedible skin, 3.5 L/ha 3 applications
Laitues, 3,5 L/ha 4 applications Lettuce, 3.5 L/ha 4 applications
Poivrons : mildiou(s), 2,5-4 L/ha 3-5 applications Peppers: mildew(s), 2.5-4 L/ha 3-5 applications
Vigne : mildiou(s) 2,5-4 L/ha 2-5 applications ; black rot (Guignardia bidwellii) 4 L/ha 4 applications; Excoriose (Phomopsis viticola) 3 L/haVine: downy mildew(s) 2.5-4 L/ha 2-5 applications; black rot (Guignardia bidwellii) 4 L/ha 4 applications; Excoriosis (Phomopsis viticola) 3 L/ha
2 applications ; rougeot parasitaire (Pseudopezicula tracheiphila), 4 L/ha2 applications; parasitic red mite (Pseudopezicula tracheiphila), 4 L/ha
5 applications 5 applications
Cultures fruitières (telles que myrtillier, groseillier, groseillier à maquereau, pêcher et nectarinier) : Champignons (pythiacées, dont Phytophthora spp), 2,5-4 L/ha 3 applications (parties aériennes) ; 10 L/ha 3 applicationsFruit crops (such as blueberry, currant, gooseberry, peach and nectarine): Fungi (Pythiaceae, including Phytophthora spp), 2.5-4 L/ha 3 applications (aerial parts); 10 L/ha 3 applications
(sol) (ground)
- Agrumes (oranger, citronnier, pamplemoussier, mandarinier, clémentinier et limettier) : Phytophthora citrophthora ; chancre du collet (Phytophthora cactorurrf) 5-8,75 L/ha 1-2 applications ; Champignons (pythiacées) 4-6 L/ha 3-4 applications Blé : septoriose ; 4 L/ha 2 applications (parties aériennes)- Citrus (orange, lemon, grapefruit, mandarin, clementine and lime): Phytophthora citrophthora; collar canker (Phytophthora cactorurrf) 5-8.75 L/ha 1-2 applications; Fungi (Pythiaceae) 4-6 L/ha 3-4 applications Wheat: Septoria; 4 L/ha 2 applications (aerial parts)
Fraisier : mildiou(s) 2,5 L/ha 3 applications Strawberry: mildew(s) 2.5 L/ha 3 applications
Framboisier : Champignons (pythiacées) 2,5 L/ha 3 applicationsRaspberry: Mushrooms (Pythiaceae) 2.5 L/ha 3 applications
Pomme de terre : mildiou(s) 4 L/ha 3 applications Potato: mildew(s) 4 L/ha 3 applications
Fruits à coque : 4 L/ha 6 applications Nuts: 4 L/ha 6 applications
Grenadier : 2,4 L/ha 3 applications Pomegranate: 2.4 L/ha 3 applications
Olivier : maladies du feuillage 2,5 L/ha 3 applications Olive tree: leaf diseases 2.5 L/ha 3 applications
Cultures florales et plantes vertes : mildiou(s) Flower crops and green plants: mildew(s)
Plantes d’intérieur et balcons : mildiou(s) Rosiers : mildiou(s) 0,5 L/10 m2 3 applications Indoor plants and balconies: mildew(s) Rose bushes: mildew(s) 0.5 L/10 m2 3 applications
Il est intéressant de trouver des solutions permettant de réduire l’utilisation de phosphonates tout en maintenant une protection efficace des cultures contre les maladies fongiques. It is of interest to find solutions to reduce the use of phosphonates while maintaining effective protection of crops against fungal diseases.
Le chitosan (ou chitosane) est un polymère naturel obtenu par la désacétylation partielle de la chitine qui est aujourd’hui largement utilisé dans de nombreux domaines d’applications. Étant donné son caractère biodégradable et non-toxique, le chitosan représente une alternative prometteuse aux produits de protection des plantes issus de l’industrie chimique. Il possède un fort potentiel dans le domaine de la lutte contre les stress biotiques où il constitue un traitement efficace contre certaines maladies. Il possède deux modes d’actions qui proviennent d’une part de ses propriétés bactério- et fongistatiques (activité anti-microbienne) et d’autre part de sa capacité à induire les défenses naturelles des plantes (SDP). En effet, grâce à son caractère cationique, les polymères de chitosan vont interagir avec les membranes cellulaires des pathogènes chargés négativement ce qui va altérer la perméabilité membranaire. Par un mécanisme éliciteur, le chitosan va également stimuler les défenses naturelles des plantes en réponse à un large spectre de phytopathogènes. Utilisé seul, un chitosan ne permet généralement pas d’aboutir à un niveau de protection équivalent à une référence fongicide de synthèse. Chitosan (or chitosan) is a natural polymer obtained by the partial deacetylation of chitin that is now widely used in many fields of application. Given its biodegradable and non-toxic nature, chitosan represents a promising alternative to plant protection products from the chemical industry. It has strong potential in the field of combating biotic stress where it constitutes an effective treatment against certain diseases. It has two modes of action that come on the one hand from its bacterio- and fungistatic properties (antimicrobial activity) and on the other hand from its ability to induce the natural defenses of plants (SDP). Indeed, thanks to its cationic character, chitosan polymers will interact with the cell membranes of negatively charged pathogens which will alter membrane permeability. Through an elicitor mechanism, chitosan will also stimulate the natural defenses of plants in response to a broad spectrum of phytopathogens. Used alone, chitosan generally does not achieve a level of protection equivalent to a synthetic fungicide reference.
Le chitosan est autorisé à la commercialisation en Europe, notamment en tant que chlorhydrate de chitosane, pour la protection de plantes variées contre les infections fongiques ou bactériennes. Est également autorisé du chitosan d’origine fongique. On peut aussi envisager utiliser de l’acétate de chitosan (obtenu avec de l’acide acétique plutôt qu’avec de l’acide chlorhydrique). Chitosan is authorised for marketing in Europe, in particular as chitosan hydrochloride, for the protection of various plants against fungal or bacterial infections. Chitosan of fungal origin is also authorised. Chitosan acetate (obtained with acetic acid rather than hydrochloric acid) may also be considered.
On peut ainsi citer la protection contre les infections fongiques des oliviers, de vignes (Vitis vinifera), des pelouses, prairies, ray-grass, des betteraves à sucre, des céréales, des pommes de terre, des légumes, des baies et petits fruits (cassis, fraises, framboises, myrtilles...), des plantes ornementales bulbeuses. Examples include protection against fungal infections of olive trees, vines (Vitis vinifera), lawns, meadows, ryegrass, sugar beets, cereals, potatoes, vegetables, berries and small fruits (blackcurrants, strawberries, raspberries, blueberries, etc.), and bulbous ornamental plants.
Le Tableau 1 fournit une liste de plantes et de pathogènes bactériens ou fongiques susceptibles d’être traités par les phosphonates ou le chitosan. Table 1 provides a list of plants and bacterial or fungal pathogens that may be treated with phosphonates or chitosan.
*plantes à parfum, alimentaires, médicinales et condimentaires *perfume, food, medicinal and condiment plants
Tableau 1. Basé sur Andrivon et al, Peut-on se passer du cuivre en protection des cultures biologiques ? Rapport d'expertise scientifique collective. INRA-DEPE Juin 2018 Table 1. Based on Andrivon et al, Can we do without copper in the protection of organic crops? Collective scientific expertise report. INRA-DEPE June 2018
Ainsi que vu plus haut, les phosphonates (phosphonate de potassium ou phosphonate de di-sodium) sont homologués contre un grand nombre de maladies fongiques et des bactérioses, pour des cultures pérennes (vigne, cultures de fruits), maraîchères (cultures appartenant à diverses familles botaniques), grandes cultures (lutte contre le mildiou de la pomme de terre, et contre quelques maladies fongiques du blé et du seigle (notamment les septorioses dues à Steptoria sp. En particulier Septoria tritici ou Septoria nodorum). Les phosphonates peuvent également être utilisés contre diverses maladies fongiques affectant des plantes à parfum, aromatiques et médicinales (PPAM), des espèces ornementales et des cultures porte-graine, ou qui se développent sur les plaies du bois. As seen above, phosphonates (potassium phosphonate or disodium phosphonate) are approved against a large number of fungal diseases and bacterial diseases, for perennial crops (vines, fruit crops), market gardens (crops belonging to various botanical families), large-scale crops (control of potato blight, and against some fungal diseases of wheat and rye (in particular septoria due to Steptoria sp. In particular Septoria tritici or Septoria nodorum). Phosphonates can also be used against various fungal diseases affecting perfume, aromatic and medicinal plants (PPAM), ornamental species and seed crops, or which develop on wood wounds.
On peut aussi utiliser le chitosan contre un grand nombre de maladies fongiques et des bactérioses, pour des cultures pérennes (vigne, cultures de fruits), maraîchères (cultures appartenant à diverses familles botaniques), grandes cultures (lutte contre le mildiou de la pomme de terre, et contre quelques maladies fongiques du blé et du seigle (notamment les fusarioses) transmises par les semences. Chitosan can also be used against a large number of fungal diseases and bacterial diseases, for perennial crops (vines, fruit crops), market gardens (crops belonging to various botanical families), large-scale crops (fight against potato blight, and against some fungal diseases of wheat and rye (notably fusarium) transmitted by seeds.
Parmi ces maladies, on peut insister notamment sur le mildiou de la vigne, causé par Plasmopara viticola, qui est l'une des deux principales maladies (avec l'oïdium) de cette culture. La lutte contre le mildiou nécessite des applications nombreuses (jusqu’à une quinzaine par an). Among these diseases, we can particularly emphasize downy mildew of the vine, caused by Plasmopara viticola, which is one of the two main diseases (with powdery mildew) of this crop. The fight against mildew requires numerous applications (up to fifteen per year).
On peut aussi citer la tavelure du pommier, causée par Venturia inaequalis, pour laquelle les vergers de pommiers reçoivent en moyenne 23 traitements fongicides/bactéricides par an (de 15 à 29 selon les régions), dont près des trois- quarts ciblent la tavelure. Les traitements à base de phosphonates pourraient également contrôler Nectria galligena responsable du chancre européen. Another example is apple scab, caused by Venturia inaequalis, for which apple orchards receive an average of 23 fungicide/bactericide treatments per year (15 to 29 depending on the region), of which nearly three-quarters target scab. Phosphonate-based treatments could also control Nectria galligena, which causes European canker.
Le mildiou de la pomme de terre causé par Phytophthora infestans est à l'origine de pertes de rendement pouvant aller jusqu'à la destruction totale de la parcelle, ou de pertes de qualité en cas d'attaques tardives. On effectue de 10 à 12 traitements en moyenne, voire jusqu'à 15 ou 20 en zone à fort risque de mildiou. P. infestans peut également occasionner d'importants dégâts sur la tomate (également de la famille des solanacée). Potato blight caused by Phytophthora infestans causes yield losses that can lead to total destruction of the plot, or quality losses in the event of late attacks. On average, 10 to 12 treatments are carried out, or up to 15 or 20 in areas at high risk of blight. P. infestans can also cause significant damage to tomatoes (also from the Solanaceae family).
La cercosporiose de la betterave est une maladie du feuillage causée par Cercospora beticola, responsable de dégâts pouvant être importants si les attaques sont précoces ou en zones irriguées. Beet leaf spot is a leaf disease caused by Cercospora beticola, which can cause significant damage if attacks occur early or in irrigated areas.
La maladie des tâches noires est causée par Alternaria brassicicola sur un large éventail d'hôtes, en particulier dans le genre Brassica, y compris un certain nombre de cultures économiquement importantes telles que le chou, le chou chinois, le chou-fleur, les graines oléagineuses, le brocoli et le canola. Black spot disease is caused by Alternaria brassicicola on a wide range of hosts, particularly in the genus Brassica, including a number of economically important crops such as cabbage, Chinese cabbage, cauliflower, oilseeds, broccoli and canola.
Le mildiou de la laitue est causé par Bremia lactucae et peut entraîner la mort des jeunes plantules. Lettuce downy mildew is caused by Bremia lactucae and can cause death of young seedlings.
La septoriose du blé est une maladie fongique due principalement à Septoria tritici et Septoria nodorum, qui affecte le blé et d'autres espèces du genre Triticum. Elle peut causer des pertes de rendement de plus de 40 %. Septoria leaf spot of wheat is a fungal disease caused mainly by Septoria tritici and Septoria nodorum, which affects wheat and other species of the genus Triticum. It can cause yield losses of more than 40%.
Alternaria solani peut causer, chez les plantes de la famille des Solanaceae, notamment la tomate et la pomme de terre, mais aussi le piment et l'aubergine, une maladie appelée alternariose ou brûlure alternarienne, se manifestant par des taches noires circulaires, dans lesquelles sont visibles des cercles concentriques, sur les feuilles des plantes, et pouvant mener à la défoliation. Alternaria solani can cause a disease called alternaria leaf spot or alternaria blight in plants of the Solanaceae family, including tomatoes and potatoes, but also peppers and eggplants, which manifests itself as circular black spots, in which concentric circles are visible, on the leaves of the plants, and can lead to defoliation.
Il apparaît donc nécessaire de continuer à utiliser les phosphonates, tout en contrôlant la quantité d’utilisation, afin d’éviter une accumulation de ce produit dans les sols. Il est également nécessaire d’améliorer l’effet du chitosan, afin de lutter contre les maladies bactériennes et/ou fongiques, tout en contrôlant sa quantité d’utilisation, notamment pour réduire les coûts. It therefore appears necessary to continue using phosphonates, while controlling the quantity of use, in order to avoid an accumulation of this product in the soil. It is also necessary to improve the effect of chitosan, in order to combat bacterial and/or fungal diseases, while controlling its amount of use, especially to reduce costs.
L’invention a pour objet une méthode de traitement d’une plante, comprenant l’application simultanée, décalée ou séparée dans le temps de (I) y-mangoustine et (II) d’un produit phytosanitaire choisi parmi (i) les phosphonates, notamment les phosphonates de potassium, et (ii) le chitosan. Il est préféré quand les composés (I) et (II) sont appliqués pour obtenir un effet de synergie (permettant ainsi d’obtenir un effet supérieur à la somme des effets individuels). L’effet recherché est notamment un effet fertilisant pour améliorer la croissance des plantes ou la croissance foliaire, ou un effet antifongique ou antibactérien pour lutter contre des bactérioses ou des maladies fongiques. En particulier, la y-mangoustine peut être apportée via un extrait de Garcinia mangostana contenant de la y-mangoustine, notamment entre 2 et 15% (en poids) de y-mangoustine. Cet extrait peut résulter de la macération de péricarpes de G. mangostana dans un solvant polaire, de préférence dans de l’éthanol. Il est préféré que la y-mangoustine et le composé (II) sont appliqués simultanément. The invention relates to a method for treating a plant, comprising the simultaneous, staggered or separate application in time of (I) y-mangostin and (II) a phytosanitary product chosen from (i) phosphonates, in particular potassium phosphonates, and (ii) chitosan. It is preferred when compounds (I) and (II) are applied to obtain a synergistic effect (thus making it possible to obtain an effect greater than the sum of the individual effects). The desired effect is in particular a fertilizing effect to improve plant growth or leaf growth, or an antifungal or antibacterial effect to combat bacteriosis or fungal diseases. In particular, y-mangostin can be provided via a Garcinia mangostana extract containing y-mangostin, in particular between 2 and 15% (by weight) of y-mangostin. This extract may result from the maceration of pericarps of G. mangostana in a polar solvent, preferably in ethanol. It is preferred that y-mangostin and compound (II) are applied simultaneously.
La y-mangoustine et le composé (II) peuvent être appliqués pour prévenir ou lutter contre des bactérioses ou des maladies fongiques, ou en tant qu’agent fertilisant pour améliorer la croissance des plantes ou la croissance foliaire. Le composé (II) peut être des phosphonates, notamment des phosphonates de potassium. Le composé (II) peut être le chitosan, notamment du chlorhydrate de chitosan. La y-mangoustine est préférentiellement appliqué à une dose comprise entre 1 et 40 g/ha, de préférence entre 1 et 8 g/ha, les phosphonates sont préférentiellement appliqués à une quantité comprise entre 250 et 4000 g/ha et le chitosan est préférentiellement appliqué à une quantité comprise entre 250 et 4000 g/ha. Une composition comprenant (I) de la y-mangoustine et (II) un produit phytosanitaire choisi parmi (i) les phosphonates, notamment les phosphonates de potassium, et (ii) le chitosan, les composés (I) et (II) préférentiellement dans des doses et un rapport permettant d’obtenir un effet de synergie, l’utilisation d’une telle composition en tant que composition fertilisante, ou de composition phytosanitaire, et/ou pour améliorer la croissance et/ou le développement et/ou la productivité de plantes et/ou la défense contre les pathogènes de plantes sont également décrits. En particulier, l'invention a pour objet un procédé de traitement des plantes, dans lequel on associe des phosphonates, notamment de potassium, et de la y- mangoustine, en particulier contenue dans un extrait de Garcinia mangostana. Le traitement appliqué aux plantes peut avoir un effet phytosanitaire et/ou stimulateur de croissance. Il peut aussi être utilisé en tant qu’engrais, fertilisant ou biostimulant. Les deux composés sont avantageusement ajoutés dans des conditions et proportions permettant d’obtenir un effet synergique (les exemples ainsi que les informations de la demande permettent à un homme du métier de déterminer les doses permettant d’observer une synergie). γ-Mangostin and compound (II) may be applied to prevent or control bacterial or fungal diseases, or as a fertilizing agent to improve plant growth or leaf growth. Compound (II) may be phosphonates, in particular potassium phosphonates. Compound (II) may be chitosan, in particular chitosan hydrochloride. γ-Mangostin is preferably applied at a rate of between 1 and 40 g/ha, preferably between 1 and 8 g/ha, phosphonates are preferably applied at a quantity of between 250 and 4000 g/ha and chitosan is preferably applied at a quantity of between 250 and 4000 g/ha. A composition comprising (I) y-mangostin and (II) a phytosanitary product selected from (i) phosphonates, in particular potassium phosphonates, and (ii) chitosan, compounds (I) and (II) preferably in doses and a ratio making it possible to obtain a synergistic effect, the use of such a composition as a fertilizing composition, or a phytosanitary composition, and/or for improving the growth and/or development and/or productivity of plants and/or defense against plant pathogens are also described. In particular, the invention relates to a method for treating plants, in which phosphonates, in particular potassium phosphonates, and y-mangostin, in particular contained in an extract of Garcinia mangostana, are combined. The treatment applied to the plants may have a phytosanitary and/or growth-stimulating effect. It may also be used as a fertilizer, fertilizer or biostimulant. The two compounds are advantageously added in conditions and proportions making it possible to obtain a synergistic effect (the examples and the information in the application allow a person skilled in the art to determine the doses making it possible to observe a synergy).
L'invention a également pour objet une composition phytosanitaire comprenant des phosphonates (ll)(i), notamment de potassium, et de la y-mangoustine (I), en particulier contenue dans un extrait de Garcinia mangostana, notamment lorsque l’extrait contient de la y-mangoustine. Cette composition contient les composés (ll)(i) et (I) dans des proportions et quantités permettant d’obtenir un effet de synergie lors de l’application. The invention also relates to a phytosanitary composition comprising phosphonates (ll)(i), in particular potassium, and y-mangostin (I), in particular contained in an extract of Garcinia mangostana, in particular when the extract contains y-mangostin. This composition contains the compounds (ll)(i) and (I) in proportions and amounts making it possible to obtain a synergistic effect during application.
Plus particulièrement, ce procédé et les compositions relatives permettent d’améliorer l’efficacité de produits phytosanitaires à base de phosphonates, en réduisant les doses de phosphonates, tout en maintenant l’effet de prévention de l’apparition ou de traitement des maladies fongiques des plantes, par exemple le mildiou de la vigne, l’alternariose des crucifères le mildiou de la laitue ou encore la septoriose du blé. More particularly, this method and the relative compositions make it possible to improve the effectiveness of phytosanitary products based on phosphonates, by reducing the doses of phosphonates, while maintaining the effect of preventing the appearance or treatment of fungal diseases of plants, for example downy mildew of grapevines, alternaria of cruciferous plants, downy mildew of lettuce or even septoria of wheat.
Ainsi, on applique des doses réduites de phosphonates associées à la y- mangoustine qui permet de potentialiser l’effet des phosphonates, via un effet synergique. Ainsi, on peut lutter efficacement contre les maladies des plantes tout en réduisant drastiquement les quantités de phosphonates appliquées par rapport aux pratiques actuelles. Thus, reduced doses of phosphonates are applied in combination with y-mangostin, which potentiates the effect of phosphonates, via a synergistic effect. Thus, plant diseases can be effectively combated while drastically reducing the quantities of phosphonates applied compared to current practices.
L’invention a également pour objet un procédé de traitement des plantes, dans lequel on associe du chitosan (ll)(ii), notamment du chlorhydrate de chitosan et de la y-mangoustine, en particulier contenue dans un extrait de Garcinia mangostana. Le traitement appliqué aux plantes peut avoir un effet phytosanitaire et/ou stimulateur de croissance. Il peut aussi être utilisé en tant qu’engrais. The invention also relates to a method for treating plants, in which chitosan (ll)(ii), in particular chitosan hydrochloride and y-mangostin, in particular contained in an extract of Garcinia mangostana, are combined. The treatment applied to the plants can have a phytosanitary and/or growth-stimulating effect. It can also be used as a fertilizer.
L'invention a également pour objet une composition phytosanitaire comprenant du chitosan (ll)(ii), notamment du chlorhydrate de chitosan, et de la y-mangoustine (I), en particulier contenue dans un extrait de Garcinia mangostana. Cette composition contient les composés (ll)(ii) et (I) dans des proportions et quantités permettant d’obtenir un effet de synergie lors de l’application. The invention also relates to a phytosanitary composition comprising chitosan (ll)(ii), in particular chitosan hydrochloride, and y-mangostin (I), in particular contained in an extract of Garcinia mangostana. This composition contains compounds (ll)(ii) and (I) in proportions and quantities enabling a synergistic effect to be obtained upon application.
Plus particulièrement, ce procédé et les compositions relatives permettent d’améliorer l’efficacité de produits phytosanitaires à base de chitosan, en réduisant potentiellement les doses de chitosan, tout en maintenant l’effet de prévention de l’apparition ou de traitement des maladies fongiques des plantes, par exemple le mildiou de la vigne, l’alternariose des crucifères ou encore le mildiou de la laitue.More particularly, this method and the relative compositions make it possible to improve the effectiveness of chitosan-based phytosanitary products, by potentially reducing the doses of chitosan, while maintaining the effect of preventing the appearance or treating fungal diseases of plants, for example downy mildew of grapevines, alternaria of cruciferous plants or even downy mildew of lettuce.
Ainsi, on peut appliquer des doses réduites de chitosan associées à la y- mangoustine qui permet de potentialiser l’effet du chitosan, via un effet synergique. Ainsi, on peut lutter efficacement contre les maladies des plantes tout en réduisant drastiquement les quantités de chitosan appliquées par rapport aux pratiques actuelles. Thus, reduced doses of chitosan can be applied in combination with y-mangostin, which can potentiate the effect of chitosan, via a synergistic effect. Thus, plant diseases can be effectively combated while drastically reducing the quantities of chitosan applied compared to current practices.
WO 2023/099609 décrit une méthode de prévention, de contrôle ou de traitement d'une infection fongique sur un organe végétal comprenant l'application sur ledit organe végétal d'une quantité non fongicide ou d'une quantité potential isatrice d'une composition comprenant un agent potentialisateur d'une molécule de défense végétale, en association avec un véhicule phytopharmaceutique. Les molécules décrites dans ce document incluent les molécules de formule générale (I). WO 2023/099609 describes a method for preventing, controlling or treating a fungal infection on a plant organ comprising applying to said plant organ a non-fungicidal amount or a potentiating amount of a composition comprising a potentiating agent of a plant defense molecule, in combination with a phytopharmaceutical vehicle. The molecules described in this document include molecules of general formula (I).
Gopalakrishnan et al (J Nat Prod. 1997 May;60(5):519-24) décrit l’isolement de plusieurs xanthones de G. mangostana, dont la y-mangoustine (composé 5), et l’analyse de leur effet antifongique. Les tableaux 3-5 montrent que la y- mangoustine est le composé le plus puissant. Gopalakrishnan et al (J Nat Prod. 1997 May;60(5):519-24) described the isolation of several xanthones from G. mangostana, including y-mangostin (compound 5), and the analysis of their antifungal effect. Tables 3-5 show that y-mangostin is the most potent compound.
Adamu et al (Materials & Design 209 (2021): 109942), Samprasit et al (Carbohydr Polym. 2015 Mar 6:117:933-940) et Charernsriwilaimat et al (Int J Pharm. 2013 Aug 16;452(1-2):333-43) décrivent des nanofibres à base de chitosan et d’un extrait de péricarpe de chitosan. Adamu et al (Materials & Design 209 (2021): 109942), Samprasit et al (Carbohydr Polym. 2015 Mar 6:117:933-940) and Charernsriwilaimat et al (Int J Pharm. 2013 Aug 16;452(1-2):333-43) describe nanofibers based on chitosan and chitosan pericarp extract.
Azman et al (Food Control, (2022) 141 , 109189) décrivent des films contenant du chitosan et des extraits de mangoustan. Azman et al (Food Control, (2022) 141, 109189) describe films containing chitosan and mangosteen extracts.
L’invention se rapporte ainsi à une méthode de traitement d’une plante, comprenant l’application simultanée, décalée ou séparée dans le temps de (I) y- mangoustine et (II) d’un produit phytosanitaire choisi parmi (i) les phosphonates, notamment les phosphonates de potassium, et (ii) le chitosan, les composés (I) et (II) étant appliqués pour obtenir un effet de synergie The invention thus relates to a method of treating a plant, comprising the simultaneous, staggered or separate application in time of (I) y-mangostin and (II) a phytosanitary product chosen from (i) phosphonates, in particular potassium phosphonates, and (ii) chitosan, compounds (I) and (II) being applied to obtain a synergistic effect
La gamma mangoustine (y-mangoustine) présente la formule (I). Gamma mangostin (y-mangostin) has the formula (I).
On rappelle que l’alpha-mangoustine présente les mêmes groupes R1-R6 et R8 que la gamma-mangoustine, mais un groupe -O-CH3 en position R7. It is recalled that alpha-mangostin has the same R1-R6 and R8 groups as gamma-mangostin, but an -O-CH3 group in position R7.
Cette molécule est présente dans la coque de mangoustan (Garcinia mangostana). On peut ainsi utiliser un extrait de Garcinia mangostana pour apporter cette molécule dans la composition à appliquer aux plantes, avec les phosphonates. This molecule is present in the mangosteen shell (Garcinia mangostana). We can thus use an extract of Garcinia mangostana to bring this molecule into the composition to be applied to plants, with phosphonates.
Dans un mode de réalisation préféré, l’extrait de G. mangostana contient de la y-mangoustine et de l’a-mangoustine. Dans certains modes de réalisation, le ratio Y-mangoustine/a-mangoustine est compris entre 1 :4 et 1 :9, ou entre 1 :6 et 1 :8.In a preferred embodiment, the G. mangostana extract contains y-mangostin and a-mangostin. In some embodiments, the ratio of Y-mangostin to a-mangostin is between 1:4 and 1:9, or between 1:6 and 1:8.
Typiquement, on utilise un extrait de Garcinia mangostana, de préférence choisi parmi l’extrait de feuille, d’écorce ou de péricarpe de Garcinia mangostana. Généralement, l’extrait est un extrait de péricarpe de Garcinia mangostana. Typically, an extract of Garcinia mangostana is used, preferably selected from the leaf, bark or pericarp extract of Garcinia mangostana. Generally, the extract is a pericarp extract of Garcinia mangostana.
Dans un mode de réalisation, cet extrait est un extrait aqueux, un extrait hydroalcoolique, un extrait éthanolique, un extrait méthanolique, un extrait d’acétate d’éthyle ou un extrait de CO2 supercritique. Ces extraits peuvent notamment être obtenus par macération de péricarpes de Garcinia mangostana dans un solvant (notamment un solvant polaire), tel que décrit. Dans un mode de réalisation, l’extrait est obtenu avec un mélange d’acétate d’éthyle et d’éthanol, typiquement dans un rapport volumétrique acétate d’éthyle:éthanol allant de 60:40 à 90:10, de 70:30 à 80:20, de 75:25 à 80:20. Dans un mode de réalisation spécifique, l’extrait est obtenu avec un mélange d’acétate d’éthyle et d’éthanol, dans un rapport volumétrique acétate d’éthyle:éthanol d’environ 75:25, d’environ 76:24, d’environ 77:23, d’environ 78:22, d’environ 79:21 , ou d’environ 80:20. Dans un mode de réalisation, on utilise l’éthanol uniquement en tant que solvant. Dans un mode de réalisation, on effectue la macération en utilisant de l’eau et de l’éthanol en tant que solvants. Dans un mode de réalisation, on effectue la macération en utilisant du CO2 supercritique et de l’éthanol en tant que solvants.In one embodiment, this extract is an aqueous extract, a hydroalcoholic extract, an ethanolic extract, a methanolic extract, an ethyl acetate extract or a supercritical CO2 extract. These extracts can in particular be obtained by maceration of pericarps of Garcinia mangostana in a solvent (in particular a polar solvent), as described. In one embodiment, the extract is obtained with a mixture of ethyl acetate and ethanol, typically in a volumetric ratio of ethyl acetate:ethanol ranging from 60:40 to 90:10, from 70:30 to 80:20, from 75:25 to 80:20. In a specific embodiment, the extract is obtained with a mixture of ethyl acetate and ethanol, in an ethyl acetate:ethanol volumetric ratio of about 75:25, about 76:24, about 77:23, about 78:22, about 79:21, or about 80:20. In In one embodiment, ethanol is used only as a solvent. In one embodiment, the maceration is carried out using water and ethanol as solvents. In one embodiment, the maceration is carried out using supercritical CO2 and ethanol as solvents.
Dans un mode de réalisation, le rapport plante : solvant est compris entre 1 :2 et 1 :10 (% poids/poids), de préférence entre 1 :4 et 1 :6. In one embodiment, the plant:solvent ratio is between 1:2 and 1:10 (% weight/weight), preferably between 1:4 and 1:6.
Les extraits peuvent être obtenus par des méthodes d’extraction assistées par ultrasons ou micro-ondes. Extracts can be obtained by ultrasound or microwave-assisted extraction methods.
On peut utiliser un extrait brut de la plante ou une partie fractionnée de celle-ci, notamment en utilisant toute méthode connue dans l’art telle qu’une chromatographie, pour fractionner un extrait brut, comme par exemple l’extraction/le fractionnement liquide-liquide et/ou la chromatographie d’adsorption/absorption. A crude extract of the plant or a fractionated portion thereof may be used, including using any method known in the art such as chromatography, to fractionate a crude extract, such as liquid-liquid extraction/fractionation and/or adsorption/absorption chromatography.
Les parties fractionnées de l’extrait brut peuvent comprendre de la y- mangoustine à des concentrations différentes. L’extrait brut de péricarpe de Garcinia mangostana peut en outre comprendre d’autres xanthones, telles que la 1 ,3,5 trihydroxy-4-prénylxanthone, la 1 ,3,5 trihydroxy-2-prénylxanthone. L’extrait brut de péricarpe de Garcinia mangostana peut en outre comprendre des xanthones, telles que l’a-mangoustine. Avantageusement, l’extrait brut de péricarpe de Garcinia mangostana peut être utilisé à une concentration où tous ses constituants se trouvent dans une quantité in vitro non directement fongicide, comme par exemple moins de 200 mg/L, moins de 150 mg/L ou moins de 100 mg/mL. On peut aussi utiliser des compositions contenant jusqu’à 1 g/L (utilisées pour fournir une dose d’environ 200 g/Ha, soit un volume de 200 L/Ha). The fractionated portions of the crude extract may comprise y-mangostin at different concentrations. The crude extract of Garcinia mangostana pericarp may further comprise other xanthones, such as 1,3,5-trihydroxy-4-prenylxanthone, 1,3,5-trihydroxy-2-prenylxanthone. The crude extract of Garcinia mangostana pericarp may further comprise xanthones, such as α-mangostin. Advantageously, the crude extract of Garcinia mangostana pericarp may be used at a concentration where all of its constituents are in an in vitro amount that is not directly fungicidal, such as less than 200 mg/L, less than 150 mg/L or less than 100 mg/mL. Compositions containing up to 1 g/L can also be used (used to provide a dose of approximately 200 g/Ha, or a volume of 200 L/Ha).
On peut obtenir un extrait final, de Garcinia mangostana comprenant de 3 à 12%, ou de 3 à 10 % p/p de y-mangoustine en poids sec par rapport au poids sec de l’extrait final. Par exemple, 100 mg d’extrait final de G. mangostana comprennent environ 6 mg de y-mangoustine. L’extrait de G. mangostana peut aussi contenir de l’alpha-mangoustine. A final extract of Garcinia mangostana comprising from 3 to 12%, or from 3 to 10% w/w of y-mangostin on a dry weight basis relative to the dry weight of the final extract can be obtained. For example, 100 mg of final extract of G. mangostana comprises about 6 mg of y-mangostin. The extract of G. mangostana may also contain alpha-mangostin.
L’homme du métier saura adapter ces quantités non fongicides si une fraction riche en y-mangoustine ou pauvre en y-mangoustine est utilisée à la place de l’extrait brut de péricarpe de Garcinia mangostana, notamment obtenu par extraction avec un solvant polaire. La méthode selon l’invention permet de diminuer les quantités de phosphonates ou de chitosan apportées pour lutter contre les pathogènes. A person skilled in the art will be able to adapt these non-fungicidal quantities if a fraction rich in y-mangostin or poor in y-mangostin is used instead of the crude extract of Garcinia mangostana pericarp, in particular obtained by extraction with a polar solvent. The method according to the invention makes it possible to reduce the quantities of phosphonates or chitosan used to combat pathogens.
Ainsi, du fait de l’existence d’une synergie entre les phosphonates et la y- mangoustine, ou le chitosan et la y-mangoustine, ainsi que montré dans les exemples, on peut diminuer la dose de phosphonates ou de chitosan, c’est-à-dire utiliser une dose plus réduite (généralement divisée par au moins 2) par rapport à la dose utilisée en pratique ou celle permettant d’obtenir un effet maximal lorsque les phosphonates ou le chitosan sont utilisés seuls. En diminuant la dose, on peut ainsi utiliser des doses ne permettant pas a priori de combattre le pathogène in vivo ou d’empêcher la croissance du pathogène in vitro. Si l’on ne diminue pas les doses, l’effet obtenu sera meilleur que lorsque les phosphonates ou le chitosan sont utilisés seuls. Thus, due to the existence of a synergy between phosphonates and y-mangostin, or chitosan and y-mangostin, as shown in the examples, the dose of phosphonates or chitosan can be reduced, i.e. a lower dose can be used (generally divided by at least 2) compared to the dose used in practice or that which allows a maximum effect to be obtained when phosphonates or chitosan are used alone. By reducing the dose, doses can thus be used which do not a priori allow the pathogen to be combated in vivo or the growth of the pathogen to be prevented in vitro. If the doses are not reduced, the effect obtained will be better than when phosphonates or chitosan are used alone.
La diminution des quantités de phosphonates ou de chitosan appliquées permet ainsi de s’affranchir de l’apparition d’effets indésirables, tout en conservant un même niveau de protection. De plus, la combinaison de deux molécules possédant des modes d’actions différents permet généralement de limiter le développement de résistance chez les microorganismes pathogènes ciblés. L’application d’agents antifongiques à des doses faibles permet d’en diminuer les effets indésirables potentiels sur la faune et la flore et d’en réduire les résidus. Reducing the quantities of phosphonates or chitosan applied thus makes it possible to avoid the occurrence of undesirable effects, while maintaining the same level of protection. In addition, the combination of two molecules with different modes of action generally makes it possible to limit the development of resistance in the targeted pathogenic microorganisms. The application of antifungal agents at low doses makes it possible to reduce their potential undesirable effects on fauna and flora and to reduce their residues.
Dans la pratique, la quantité de phosphonates ou de chitosan apportée par hectare dépend essentiellement du type de plantes à protéger, de la pluviométrie, et de la pression parasitaire. In practice, the quantity of phosphonates or chitosan applied per hectare depends essentially on the type of plants to be protected, rainfall, and pest pressure.
Du fait de la présence des molécules de formule (I), on peut ainsi réduire la quantité de phosphonates ou de chitosan à appliquer par hectare à chaque traitement. Due to the presence of molecules of formula (I), it is possible to reduce the quantity of phosphonates or chitosan to be applied per hectare at each treatment.
Ainsi, on peut envisager de diminuer la dose annuelle de phosphonates ou de chitosan, si l’on conserve le même nombre d’applications, ou d’augmenter le nombre d’applications et/ou la fréquence entre deux applications, en mettant en œuvre le procédé selon l’invention, du fait de la diminution de la dose par application. Thus, it is possible to consider reducing the annual dose of phosphonates or chitosan, if the same number of applications is maintained, or to increase the number of applications and/or the frequency between two applications, by implementing the method according to the invention, due to the reduction in the dose per application.
Dans un mode de réalisation, les phosphonates et la y-mangoustine, en particulier dans un extrait de G. mangostana sont appliquées simultanément. En particulier, on prépare une composition comprenant à la fois les phosphonates et la y-mangoustine. Selon un autre mode de réalisation, les phosphonates et la y-mangoustine sont administrées simultanément ou successivement, par application sur les plantes (notamment pulvérisation, épandage, arrosage) ou tout autre moyen permettant de fournir les phosphonates et la y-mangoustine au lieu (site) infecté ou susceptible de l’être. On peut commencer par appliquer les phosphonates puis la y- mangoustine, ou apporter d’abord la y-mangoustine puis les phosphonates. In one embodiment, the phosphonates and y-mangostin, particularly in an extract of G. mangostana are applied simultaneously. In particular, a composition comprising both the phosphonates and y-mangostin is prepared. In another embodiment, the phosphonates and y-mangostin are administered simultaneously or successively, by application to the plants (in particular spraying, spreading, watering) or any other means making it possible to provide the phosphonates and y-mangostin to the infected or susceptible place (site). It is possible to start by applying the phosphonates then the y-mangostin, or to provide first the y-mangostin then the phosphonates.
Selon un mode de réalisation, les phosphonates et la y-mangoustine sont mélangées dans un même récipient ou placées dans deux récipients séparés.According to one embodiment, the phosphonates and γ-mangostin are mixed in the same container or placed in two separate containers.
On apporte généralement les phosphonates à une quantité comprise entre 250 et 4000 g/ha (gramme par hectare), de préférence entre 500 et 1000 g/ha, de préférence entre 600 et 900 g/ha, de préférence entre 700 et 800 g/ha. Du fait de la synergie, on peut aussi envisager de diminuer les doses appliquées. Phosphonates are generally applied at a rate of between 250 and 4000 g/ha (grams per hectare), preferably between 500 and 1000 g/ha, preferably between 600 and 900 g/ha, preferably between 700 and 800 g/ha. Due to the synergy, it is also possible to consider reducing the doses applied.
Dans un mode de réalisation préféré, les phosphonates sont des phosphonates de potassium. Dans un autre mode de réalisation, les phosphonates sont des phosphonates de di-sodium. In a preferred embodiment, the phosphonates are potassium phosphonates. In another embodiment, the phosphonates are disodium phosphonates.
Dans un mode de réalisation, le chitosan et la y-mangoustine, en particulier dans un extrait de G. mangostana sont appliquées simultanément. En particulier, on prépare une composition comprenant à la fois le chitosan et la y-mangoustine.In one embodiment, chitosan and y-mangostin, particularly in an extract of G. mangostana are applied simultaneously. In particular, a composition comprising both chitosan and y-mangostin is prepared.
Selon un autre mode de réalisation, le chitosan et la y-mangoustine sont administrées simultanément ou successivement, par application sur les plantes (notamment pulvérisation, épandage, arrosage) ou tout autre moyen permettant de fournir le chitosan et la y-mangoustine au lieu (site) infecté ou susceptible de l’être. On peut commencer par appliquer le chitosan puis la y-mangoustine, ou apporter d’abord la y-mangoustine puis le chitosan. In another embodiment, the chitosan and γ-mangostin are administered simultaneously or successively, by application to the plants (in particular spraying, spreading, watering) or any other means making it possible to provide the chitosan and γ-mangostin to the infected or susceptible place (site). It is possible to start by applying the chitosan then the γ-mangostin, or to provide first the γ-mangostin then the chitosan.
Selon un mode de réalisation, le chitosan et la y-mangoustine sont mélangés dans un même récipient ou placées dans deux récipients séparés. According to one embodiment, the chitosan and the γ-mangostin are mixed in the same container or placed in two separate containers.
Selon un mode de réalisation de l’invention, la quantité de chitosan apportée par hectare est comprise entre 10 et 1000 g/ha, de préférence entre 20 et 90 g/ha, préférentiellement entre 30 et 80 g/ha, plus préférentiellement entre 40 et 160 g/ha par administration. On peut toutefois appliquer des doses supérieures selon la nature et qualité du chitosan. Du fait de la synergie, on peut aussi envisager de diminuer les doses appliquées. According to one embodiment of the invention, the amount of chitosan applied per hectare is between 10 and 1000 g/ha, preferably between 20 and 90 g/ha, preferentially between 30 and 80 g/ha, more preferentially between 40 and 160 g/ha per administration. However, higher doses can be applied depending on the nature and quality of the chitosan. Due to the synergy, it is also possible to consider reducing the doses applied.
En protection des cultures, le chitosan se trouve généralement sous la forme de chlorhydrate de chitosan. On trouve désormais aussi du chitosan d’origine fongique. On peut aussi fabriquer un sel d’acétate de chitosan, avec de l’acide acétique. In crop protection, chitosan is usually found in the form of chitosan hydrochloride. Nowadays, chitosan of the original type is also available. fungal. Chitosan acetate salt can also be made with acetic acid.
Dans un mode de réalisation, la quantité de y-mangoustine apportée par hectare selon l’invention est comprise entre 1 et 40 g/ha, de préférence entre 1 et 15 g/ha, préférentiellement entre 1 ,5 et 10 g/ha, plus préférentiellement entre 4 et 8 g par hectare. In one embodiment, the amount of y-mangostin supplied per hectare according to the invention is between 1 and 40 g/ha, preferably between 1 and 15 g/ha, preferentially between 1.5 and 10 g/ha, more preferentially between 4 and 8 g per hectare.
Selon un mode de réalisation, la composition est sous forme liquide. Elle est administrée par pulvérisation ou par arrosage. Dans un autre mode de réalisation, la composition est sous une forme permettant l’enrobage ou le pelliculage de semences : ceci est particulièrement adapté pour la lutte ou la prévention des fusarioses racinaires touchant les céréales. According to one embodiment, the composition is in liquid form. It is administered by spraying or watering. In another embodiment, the composition is in a form allowing the coating or film-coating of seeds: this is particularly suitable for the control or prevention of root fusarium diseases affecting cereals.
Dans un mode de réalisation, les phosphonates, notamment de potassium ou le chitosan, et la y-mangoustine, en particulier en tant qu’extrait de G. mangostana, sont appliquées pour prévenir ou lutter contre des bactérioses ou des maladies fongiques. En particulier ces éléments peuvent être utilisés pour prévenir ou lutter contre les maladies mentionnées dans le Tableau 1 , pour les plantes considérées. On peut toutefois mettre l’accent sur la prévention ou la lutte contre la tavelure du pommier (Venturia inaequalis)_, le mildiou en particulier de la vigne, de la laitue ou de la pomme de terre, les infections à Botrytis en particulier sur vigne et tomate, les infections à Fusarium en particulier sur céréales (blé et orge), la septoriose de céréales, les infections à Septoria sp. en particulier la septoriose du blé, l’alternariose des crucifères ou des solanacées ou la cercosporiose de la betterave (Cercospora beticolà). On note particulièrement le mildiou de la laitue, le mildiou de la pomme de terre, l’alternariose du chou et la septoriose du blé. Les deux composés sont particulièrement intéressants contre Altenaria solani, Venturia inaequalis ou Alternaria brassicicola, ou les pathogènes responsables des autres maladies citées dans cette demande. In one embodiment, phosphonates, in particular potassium or chitosan, and y-mangostin, in particular as an extract of G. mangostana, are applied to prevent or combat bacterial diseases or fungal diseases. In particular, these elements can be used to prevent or combat the diseases mentioned in Table 1, for the plants considered. However, emphasis can be placed on the prevention or control of apple scab (Venturia inaequalis), mildew in particular of vines, lettuce or potatoes, Botrytis infections in particular on vines and tomatoes, Fusarium infections in particular on cereals (wheat and barley), cereal septoria, Septoria sp. infections in particular wheat septoria, cruciferous or solanaceae alternaria or beet leaf spot (Cercospora beticolà). Of particular note are lettuce downy mildew, potato downy mildew, cabbage leaf blight and wheat leaf blight. Both compounds are particularly interesting against Altenaria solani, Venturia inaequalis or Alternaria brassicicola, or the pathogens responsible for the other diseases cited in this application.
Les phosphonates et le chitosan peuvent également être utilisés dans des engrais. En effet, ils permettent de renforcer la vigueur des plantes, en tant qu’éliciteurs de défenses naturelles. Ainsi, les phosphonates ou le chitosan et la y- mangoustine peuvent être utilisés en tant qu’engrais ou agent fertilisant pour améliorer la croissance de plantes ou la croissance foliaire. Dans ce mode d’utilisation, on apporte également préférentiellement d’autres composés (oligoéléments tels que manganèse, zinc, fer, bore, silicium, voire molybdène...) qui sont également utiles, voire essentiels à la croissance des plantes. Phosphonates and chitosan can also be used in fertilizers. Indeed, they help to strengthen the vigor of plants, as elicitors of natural defenses. Thus, phosphonates or chitosan and y-mangostin can be used as fertilizers or fertilizing agents to improve plant growth or foliar growth. In this mode of use, we also preferentially provide other compounds (trace elements such as manganese, zinc, iron, boron, silicon, even molybdenum, etc.) which are also useful, even essential for plant growth.
L’invention se rapporte également à une composition pour application sur des plantes comprenant des phosphonates, notamment de potassium, et de la y- mangoustine, en particulier en tant qu’extrait de G. mangostana. L’invention se rapporte également à une composition pour application sur des plantes comprenant du chitosan, notamment du chlorhydrate de chitosan, et de la y- mangoustine, en particulier en tant qu’extrait de G. mangostana. The invention also relates to a composition for application to plants comprising phosphonates, in particular potassium phosphonates, and y-mangostin, in particular as an extract of G. mangostana. The invention also relates to a composition for application to plants comprising chitosan, in particular chitosan hydrochloride, and y-mangostin, in particular as an extract of G. mangostana.
Ces compositions peuvent être utilisées en tant qu’agent fertilisant, ou agent phytosanitaire, en particulier selon les concentrations des deux éléments qui sont présents. Elles présentent donc des avantages pour la croissance et/ou la nutrition et/ou la santé des plantes. These compositions can be used as a fertilizing agent, or a phytosanitary agent, in particular depending on the concentrations of the two elements that are present. They therefore have advantages for the growth and/or nutrition and/or health of plants.
Il est entendu que les concentrations de chacun des composés sont déterminées par l’homme du métier, et peuvent être augmentées ou diminuées, selon la quantité de composition que l’on désire appliquer par hectare, et de la dilution de composition « mère » avant application. Ainsi, en fonction de la nature de la plante à traiter, du pathogène envisagé (et de la force de l’attaque de ce pathogène) ou de l’utilisation en tant qu’agent fertilisant, les quantités peuvent être faibles, ou élevées. It is understood that the concentrations of each of the compounds are determined by the person skilled in the art, and can be increased or decreased, depending on the quantity of composition that one wishes to apply per hectare, and the dilution of the “mother” composition before application. Thus, depending on the nature of the plant to be treated, the pathogen envisaged (and the strength of the attack of this pathogen) or the use as a fertilizing agent, the quantities can be low, or high.
On mélange avantageusement les phosphonates ou le chitosan avec un extrait de G. mangostana, ainsi que vu plus haut, qui apporte la y-mangoustine. Phosphonates or chitosan are advantageously mixed with an extract of G. mangostana, as seen above, which provides y-mangostin.
On fabrique généralement une composition « mère » destinée à être diluée (généralement 1 :100 ou 0,5:100 (v:v)) avant application sur les végétaux. Les quantités appliquées sont préférentiellement celles mentionnées plus haut. On applique généralement la composition après dilution appropriée, sur les feuilles ou fruits de la plante (application foliaire ou sur fruits), par pulvérisation. On peut toutefois appliquer la composition après dilution appropriée, au pied de la plante. A "mother" composition is generally made to be diluted (generally 1:100 or 0.5:100 (v:v)) before application to plants. The quantities applied are preferably those mentioned above. The composition is generally applied after appropriate dilution, to the leaves or fruits of the plant (foliar or fruit application), by spraying. However, the composition can be applied after appropriate dilution, at the base of the plant.
Elle peut se présenter sous la forme d’une suspension, émulsion ou dispersion dans une phase préférentiellement aqueuse, mais également sous la forme d’une poudre ou de granulés ou tablettes. Dans ces derniers modes de réalisations, on ajoute de l’eau avant administration, pour obtenir les quantités de phosphonates ou de chitosan et de y-mangoustine adéquates. La composition peut également contenir des oligoéléments (zinc, bore, manganèse, silicium, fer...) pour pouvoir apporter les éléments utiles pour la croissance des plantes, et avoir un effet fertilisant. Elle contient également préférentiellement des co-formulants (choisis notamment parmi les agents de textures, agent mouillants, tensio-actifs, suspenseurs, émulsifiants, conservateurs...) adaptés selon l’application envisagée (administration par pulvérisation sur les feuilles, au pied de la plante, dans l’eau d’arrosage...). It can be in the form of a suspension, emulsion or dispersion in a preferably aqueous phase, but also in the form of a powder or granules or tablets. In these latter embodiments, water is added before administration, to obtain the adequate quantities of phosphonates or chitosan and y-mangostin. The composition may also contain trace elements (zinc, boron, manganese, silicon, iron, etc.) to provide the elements useful for plant growth and have a fertilizing effect. It also preferably contains co-formulants (chosen in particular from texturizing agents, wetting agents, surfactants, suspenders, emulsifiers, preservatives, etc.) adapted according to the intended application (administration by spraying on the leaves, at the base of the plant, in the watering water, etc.).
L’invention se rapporte également à un procédé de fabrication d’une composition telle que décrite comprenant l’incorporation simultanément ou successivement d’au moins des phosphonates, notamment de potassium, ou de chitosan, notamment de chlorhydrate de chitosan et de y-mangoustine avec des agents co-formulants. Ces éléments peuvent ensuite être mélangés pour obtenir une suspension, une émulsion ou une dispersion dans une phase préférentiellement aqueuse. The invention also relates to a method for manufacturing a composition as described comprising the simultaneous or successive incorporation of at least phosphonates, in particular potassium phosphonates, or chitosan, in particular chitosan hydrochloride and γ-mangostin with co-formulating agents. These elements can then be mixed to obtain a suspension, an emulsion or a dispersion in a preferably aqueous phase.
Il est rappelé que les agents co-formulants incluent des surfactants (tensioactifs), pour réduire la tension superficielle entre les liquides et les surfaces et améliorer la dispersion et l'adhésion des agents actifs (notamment des alkylphénol éthoxylates, polysorbates), des adjuvants qui augmentent la pénétration des agents actifs dans les plantes (huiles minérales, huiles végétales, agents mouillants), des agents de suspension pour maintenir les particules solides en suspension dans les formulations liquides (bentonite, silice colloïdale), des stabilisateurs pour éviter la décomposition des agents actifs par des facteurs environnementaux tels que la lumière, la chaleur ou l'oxygène (antioxydants, absorbeurs UV), des solvants permettant la dissolution des agents actifs pour créer une formulation homogène et faciliter l'application (solvants organiques comme le xylène, l'acétone, l'éthanol), des agents de séquestration pour lier les ions métalliques qui pourraient autrement inactiver les agents actifs (EDTA (acide éthylènediaminetétraacétique), acide citrique), des polymères ou gélifiants, des agents de pénétration (éthoxylates d'alcool, sulfosuccinates), des tampons et agents de pH (acide citrique, phosphates), ou des agents de dispersion. It is recalled that co-formulating agents include surfactants (surfactants), to reduce the surface tension between liquids and surfaces and improve the dispersion and adhesion of active agents (in particular alkylphenol ethoxylates, polysorbates), adjuvants that increase the penetration of active agents into plants (mineral oils, vegetable oils, wetting agents), suspending agents to maintain solid particles in suspension in liquid formulations (bentonite, colloidal silica), stabilizers to prevent decomposition of active agents by environmental factors such as light, heat or oxygen (antioxidants, UV absorbers), solvents allowing the dissolution of active agents to create a homogeneous formulation and facilitate application (organic solvents such as xylene, acetone, ethanol), sequestration agents to bind metal ions that could otherwise inactivate the active agents (EDTA (ethylenediaminetetraacetic acid), citric acid), polymers or gelling agents, penetrating agents (alcohol ethoxylates, sulfosuccinates), buffers and pH agents (citric acid, phosphates), or dispersing agents.
L’invention se rapporte également à l’utilisation de la composition telle que décrite pour améliorer la croissance et/ou le développement et/ou la productivité de plantes. L’invention se rapporte également à l’utilisation de la composition telle que décrite pour lutter ou prévenir une infection de plantes, notamment une infection bactérienne ou fongique. The invention also relates to the use of the composition as described for improving the growth and/or development and/or productivity of plants. The invention also relates to the use of the composition as as described to control or prevent a plant infection, particularly a bacterial or fungal infection.
L’invention se rapporte également à la composition telle que décrite, ou à son utilisation, en tant que produit fertilisant (permettant d’améliorer la croissance et/ou le développement et de la productivité de plantes). L’invention se rapporte également à la composition telle que décrite, ou à son utilisation, en tant que produit phytosanitaire (pour son effet antifongique permettant de lutter ou prévenir une infection de plantes, notamment une infection bactérienne ou fongique). The invention also relates to the composition as described, or to its use, as a fertilizer product (for improving the growth and/or development and productivity of plants). The invention also relates to the composition as described, or to its use, as a phytosanitary product (for its antifungal effect for combating or preventing a plant infection, in particular a bacterial or fungal infection).
EXEMPLES EXAMPLES
Exemple 1. Définition des indicateurs Example 1. Definition of indicators
Efficacité : Indicateur permettant de quantifier l’effet d’un produit phytosanitaire sur la diminution des dommages (sévérité ou incidence) causés par une maladie des plantes. Celle-ci est calculée à partir de la formule d’Abbott présentée ci-dessous : Efficacy: Indicator for quantifying the effect of a plant protection product on reducing damage (severity or incidence) caused by a plant disease. This is calculated using the Abbott formula presented below:
Synergie : Correspond à l’interaction entre au moins deux produits dont les effets combinés sont supérieurs à la somme de leurs propres effets (effet de type « un plus un est supérieur à deux »). Synergy: Corresponds to the interaction between at least two products whose combined effects are greater than the sum of their own effects (effect of the type “one plus one is greater than two”).
Ratio R : Indicateur permettant de décrire la relation existante entre deux produits phytosanitaires au regard de l’efficacité obtenue par leur application combinée. Cette relation pouvant être de trois types : R ratio: Indicator used to describe the relationship between two plant protection products with regard to the effectiveness obtained by their combined application. This relationship can be of three types:
- Antagoniste : l’efficacité obtenue par la co-application est plus faible que la somme des efficacités des deux produits appliqués seuls (type 1+1 < 2) ;- Antagonistic: the efficacy obtained by co-application is lower than the sum of the efficacies of the two products applied alone (type 1+1 < 2);
- Additive : l’efficacité obtenue par la co-application est identique à la somme des efficacités des deux produits appliqués seuls (type 1+1 = 2) ; - Additive: the efficiency obtained by co-application is identical to the sum of the efficacies of the two products applied alone (type 1+1 = 2);
Synergique : l’efficacité obtenue par la co-application est supérieure à la somme des efficacités des deux produits appliqués seuls (type 1+1 > 2). Synergistic: the efficacy obtained by co-application is greater than the sum of the efficacies of the two products applied alone (type 1+1 > 2).
Le ratio R est calculé en divisant l’efficacité observée (EObs) par la combinaison des produits par l’efficacité théorique (E^éo) : The R ratio is calculated by dividing the observed efficiency (E O bs) by the combination of products by the theoretical efficiency (E^éo):
D > obs ~ c F - t/iéo L’efficacité théorique est calculée selon la formule de Colby présentée ci- dessous, où X et Y sont les efficacités observées pour les deux produits appliqués seuls. D > o bs ~ c F - t/iéo The theoretical efficiency is calculated according to the Colby formula presented below, where X and Y are the observed efficiencies for the two products applied alone.
Ainsi, si le ratio R est inférieur à 1 , la relation entre les deux produits est antagoniste, lorsqu’il est égal à 1 , les produits sont additifs et quand il est supérieur à 1 , la relation est synergique. Par conséquent, le ratio R est un outil permettant d’évaluer le niveau de synergie entre deux produits, avec une synergie d’autant plus importante que R est grand. Thus, if the ratio R is less than 1, the relationship between the two products is antagonistic, when it is equal to 1, the products are additive and when it is greater than 1, the relationship is synergistic. Therefore, the ratio R is a tool for assessing the level of synergy between two products, with synergy being all the more important as R is large.
Exemple 2. Obtention d’un extrait de G. mangostana Example 2. Obtaining an extract of G. mangostana
Cent grammes (100g) de péricarpes séchés et broyés de Garcinia mangostana ont été extraits deux fois par macération à l'éthanol avec rapport poids volume de 1 :4, ce qui a permis d'obtenir 10 g d'extrait brut sec de G. mangostana. Le rendement moyen de l'extraction était donc de 10% poids/poids soit 100 g d'extrait brut produit pour 1000 g de péricarpes de Garcinia mangostana séchés et broyés. L'analyse par chromatographie en couche mince de l'extrait brut a indiqué la présence de y- mangoustine, qui a été confirmée par spectrométrie RMN. One hundred grams (100g) of dried and ground pericarps of Garcinia mangostana were extracted twice by ethanol maceration with a weight-volume ratio of 1:4, which gave 10 g of dry crude extract of G. mangostana. The average extraction yield was therefore 10% w/w, i.e. 100 g of crude extract produced per 1000 g of dried and ground pericarps of Garcinia mangostana. Thin-layer chromatography analysis of the crude extract indicated the presence of y-mangostin, which was confirmed by NMR spectrometry.
L’analyse d’une solution à 100 mg/L de l'extrait brut de péricarpe de Garcinia mangostana a montré une quantité de 5,9 mg/L de y-mangoustine dans cet extrait. Analysis of a 100 mg/L solution of the crude extract of Garcinia mangostana pericarp showed an amount of 5.9 mg/L of y-mangostin in this extract.
Dans un autre procédé, les péricarpes de Garcinia mangostana broyés sont extraits deux fois avec de l'éthanol comme solvant, avec un rapport plante/solvant allant de 1 :4 à 1 :8 (% w/w) pour chaque extraction, à température ambiante. Le rendement moyen de l'extraction est compris entre 6 et 15 %, c'est-à-dire qu'entre 6 et 15 g d'extrait de péricarpes de Garcinia mangostana sont obtenus en utilisant 100 g de péricarpes de Garcinia mangostana comme matière première. L'extrait obtenu est composé de y-mangoustine dans une proportion allant de 3 à 12 % (% p/p), et d'a-mangoustine dans une proportion allant de 20 à 50 % (% p/p). In another method, the crushed Garcinia mangostana pericarps are extracted twice with ethanol as solvent, with a plant/solvent ratio ranging from 1:4 to 1:8 (% w/w) for each extraction, at room temperature. The average extraction yield is between 6 and 15%, i.e. between 6 and 15 g of Garcinia mangostana pericarp extract are obtained using 100 g of Garcinia mangostana pericarps as raw material. The extract obtained is composed of y-mangostin in a proportion ranging from 3 to 12% (% w/w), and a-mangostin in a proportion ranging from 20 to 50% (% w/w).
Dans un autre procédé, les péricarpes de Garcinia mangostana broyés sont extraits avec du CO2 supercritique comme solvant et de l'éthanol comme cosolvant (30%), dans des conditions adaptées de température, de pression et de débit du solvant et du co-solvant. Le rendement moyen de l'extraction est compris entre 6 et 15 %, c'est-à-dire qu'entre 6 et 15 g d'extrait de péricarpes de Garcinia mangostana sont obtenus en utilisant 100 g de péricarpes de Garcinia mangostana comme matière première. L'extrait obtenu est composé de y-mangoustine dans une proportion allant de 3 à 12 % (% p/p), et d'a-mangoustine dans une proportion allant de 20 à 50 % (% p/p). In another process, crushed Garcinia mangostana pericarps are extracted with supercritical CO2 as solvent and ethanol as co-solvent (30%), under suitable conditions of temperature, pressure and flow rate of the solvent and co-solvent. The average extraction yield is between 6 and 15%, i.e. between 6 and 15 g of Garcinia mangostana pericarp extract are obtained using 100 g of Garcinia mangostana pericarp as raw material. The extract obtained is composed of y-mangostin in a proportion ranging from 3 to 12% (% w/w), and a-mangostin in a proportion ranging from 20 to 50% (% w/w).
Dans un autre procédé, les péricarpes de Garcinia mangostana broyés sont extraits avec un mélange eau : éthanol (70 : 30 en volume) comme solvant, avec un rapport plante/solvant allant de 1 :4 à 1 :16 (% w/w) pour chaque extraction, à température ambiante. Le rendement moyen de l'extraction est compris entre 6 et 15 %, c'est-à-dire qu'entre 6 et 15 g d'extrait de péricarpes de Garcinia mangostana sont obtenus en utilisant 100 g de péricarpes de Garcinia mangostana comme matière première. L'extrait obtenu est composé de y-mangoustine dans une proportion allant de 3 à 12 % (% p/p), et d'a-mangoustine dans une proportion allant de 20 à 50 % (% p/p). In another method, the crushed Garcinia mangostana pericarps are extracted with a water:ethanol mixture (70:30 by volume) as solvent, with a plant/solvent ratio ranging from 1:4 to 1:16 (% w/w) for each extraction, at room temperature. The average extraction yield is between 6 and 15%, i.e. between 6 and 15 g of Garcinia mangostana pericarp extract are obtained using 100 g of Garcinia mangostana pericarps as raw material. The extract obtained is composed of y-mangostin in a proportion ranging from 3 to 12% (% w/w), and a-mangostin in a proportion ranging from 20 to 50% (% w/w).
Ces méthodes utilisant notamment de l’éthanol en tant que solvant donnent donc des résultats et des extraits équivalents, en ce qui concerne la quantité de y- mangoustine. These methods, using ethanol as a solvent in particular, therefore give equivalent results and extracts, with regard to the quantity of y-mangostin.
Exemple 3. Synergie entre un extrait de Garcinia mangostana (MCE ou GME) et les phosphonates de potassium - essais in planta sur la septoriose du blé (Septoria tritici). Example 3. Synergy between an extract of Garcinia mangostana (MCE or GME) and potassium phosphonates - in planta tests on wheat septoria (Septoria tritici).
On a utilisé des phosphonates de potassium à une dose de 151 mg/L, seuls et en association avec le GME à 247,5 mg/L. Potassium phosphonates were used at a dose of 151 mg/L, alone and in combination with GME at 247.5 mg/L.
Les résultats sont présentés dans le tableau 2. The results are presented in Table 2.
Tableau 2. Essais sur la septoriose du blé in planta. Il résulte de cet essai que la combinaison de l’extrait de G. mangostana et des phosphonates permet d’améliorer les performances de chacun des produits. Une synergie a été observée. Table 2. In planta trials on wheat septoria. This test shows that the combination of G. mangostana extract and phosphonates improves the performance of each product. A synergy was observed.
D’autres essais (GME 200 pM + PYGMALION® (De Sangosse, France) 0,5% ou 1%) ont montré un ratio de synergie entre 1,1 et 1 ,6. Other trials (GME 200 pM + PYGMALION® (De Sangosse, France) 0.5% or 1%) showed a synergy ratio between 1.1 and 1.6.
Exemple 4. Synergie entre l’extrait de G. mangostana et les phosphonates de potassium - essais in planta sur le mildiou de la pomme de terre (Phytophthora infestans) Example 4. Synergy between G. mangostana extract and potassium phosphonates - in planta trials on potato late blight (Phytophthora infestans)
On a utilisé des phosphonates de potassium à une dose de 151 mg/L, seuls et en association avec le GME à 247,5 mg/L. Potassium phosphonates were used at a dose of 151 mg/L, alone and in combination with GME at 247.5 mg/L.
Les résultats sont présentés dans le tableau 3. The results are presented in Table 3.
Tableau 3 : Essais sur le mildiou de la pomme de terre in planta. Table 3: In planta potato blight trials.
Une synergie est observée en conditions in planta avec un gain de protection non négligeable par rapport aux produits utilisés seuls. A synergy is observed in in planta conditions with a significant gain in protection compared to products used alone.
Exemple 5. Synergie entre l’extrait de G. mangostana (GME) et les phosphonates de potassium - essais in planta sur Bremia lactucae (mildiou de la laitue) Example 5. Synergy between G. mangostana extract (GME) and potassium phosphonates - in planta trials on Bremia lactucae (lettuce downy mildew)
En utilisant le GME (1900 mg/L) et du PYGMALION® (phosphonates) à 1%, on a observé un ratio de synergie compris entre 1,8 et 2,3. Using GME (1900 mg/L) and PYGMALION® (phosphonates) at 1%, a synergy ratio between 1.8 and 2.3 was observed.
Exemple 6. Synergie entre un extrait de G. mangostana (GME) et les phosphonates de potassium - essais in vitro sur Plasmopara viticola (mildiou de la vigne) En utilisant le GME (1 ,5 et 2 mg/L) et du LBG 01 F34 (phosphonates de potassium, De Sangosse, France) à 0,0015% et 0,003%, on a observé un ratio de synergie compris entre 1 ,3 et 2,0. Example 6. Synergy between a G. mangostana extract (GME) and potassium phosphonates - in vitro tests on Plasmopara viticola (vine mildew) Using GME (1.5 and 2 mg/L) and LBG 01 F34 (potassium phosphonates, De Sangosse, France) at 0.0015% and 0.003%, a synergy ratio between 1.3 and 2.0 was observed.
Exemple 1. Synergie entre un extrait de Garcinia mangostana et de chlorhydrate de chitosan - essais in vitro sur Alternaria brassicicola (alternariose du chou), Example 1. Synergy between an extract of Garcinia mangostana and chitosan hydrochloride - in vitro tests on Alternaria brassicicola (alternaria of cabbage),
On a utilisé des doses de 200 mg/L de chlorhydrate de chitosan, seules et en association avec le GME à 247,5 mg/L à l’aide de la néphélométrie afin d’étudier leur effet inhibiteur sur la croissance d’Alternaria brassicicola, pathogène responsable de l’alternariose du chou. Doses of 200 mg/L of chitosan hydrochloride, alone and in combination with GME at 247.5 mg/L, were used using nephelometry to study their inhibitory effect on the growth of Alternaria brassicicola, a pathogen responsible for cabbage early blight.
Pour cela, chaque dose seule et en combinaison a été appliquée à une suspension d’Alternaria brassicicola pendant une durée de 4h. Les 4 heures révolues, la suspension est diluée en cascade jusqu’à atteindre une concentration de 1*103 conidies par mL de PDB (Potato Dextrose Broth). Les différentes modalités sont ensuite réparties dans une plaque 96 puits placée dans un néphélomètre à 25°C pour 338 cycles de 600 s, soit au total environ 56h, pour monitorer la croissance de l’agent pathogène soumis aux différentes conditions. Les données sont ensuite analysées à l’aide du logiciel Omega data analysis afin d’obtenir des aires sous la courbe et calculer des pourcentages d’inhibition présentés dans le tableau 4. For this, each dose alone and in combination was applied to a suspension of Alternaria brassicicola for a period of 4 hours. After 4 hours, the suspension is diluted in cascade until reaching a concentration of 1*10 3 conidia per mL of PDB (Potato Dextrose Broth). The different modalities are then distributed in a 96-well plate placed in a nephelometer at 25°C for 338 cycles of 600 s, or a total of approximately 56 hours, to monitor the growth of the pathogen subjected to the different conditions. The data are then analyzed using Omega data analysis software to obtain areas under the curve and calculate inhibition percentages presented in Table 4.
Il résulte de cet essai que la combinaison de l’extrait de G. mangostana et du chlorhydrate de chitosan permet d’améliorer les performances de chacun des produits. Une synergie a été observée. Au-delà d’obtenir un simple ratio de synergie, une amélioration des performances en termes d’inhibition de la croissance de l’agent pathogène est également observée par rapport à un simple effet additif entre le GME et le chitosan. Example 8. Synergie entre l’extrait de G. manqostana et de chlorhydrate de chitosan - essais in planta sur la septoriose du blé This test shows that the combination of G. mangostana extract and chitosan hydrochloride improves the performance of each product. A synergy was observed. Beyond obtaining a simple synergy ratio, an improvement in performance in terms of inhibition of the growth of the pathogen is also observed compared to a simple additive effect between GME and chitosan. Example 8. Synergy between G. manqostana extract and chitosan hydrochloride - in planta trials on wheat septoria
Une étude in planta a été réalisée afin d’étudier la compatibilité, et une potentielle synergie, entre le GME et le chlorhydrate de chitosan dans la lutte contre la septoriose du blé. An in planta study was carried out to investigate the compatibility, and a potential synergy, between GME and chitosan hydrochloride in the control of wheat septoria.
On a appliqué le chlorhydrate de chitosan à 200 mg/L. Chitosan hydrochloride was applied at 200 mg/L.
Le GME est utilisé à 247,5 mg/L. GME is used at 247.5 mg/L.
Une synergie est ainsi observée en conditions in planta avec un gain de protection non négligeable par rapport aux produits utilisés seuls, dont le chitosan à dose réduite. A synergy is thus observed in in planta conditions with a significant gain in protection compared to products used alone, including chitosan at a reduced dose.
Exemple 9. Synergie entre un extrait de G. mangostana (GME) et du chlorhydrate de chitosan - essais in vitro sur Bremia lactucae (mildiou de la laitue) Example 9. Synergy between G. mangostana extract (GME) and chitosan hydrochloride - in vitro tests on Bremia lactucae (lettuce downy mildew)
On obtient les résultats suivants (dose de 247,5 mg/L pour le GME, 200 mg/L pour le chitosan) The following results are obtained (dose of 247.5 mg/L for GME, 200 mg/L for chitosan)
Tableau 6 : Essais sur Bremia lactucae in planta. Table 6: Tests on Bremia lactucae in planta.
D’autres essais in planta (GME 1900 mg/L, chlorhydrate de chitosan 0,05%) ont montré un ratio de synergie de l’ordre de 2,5. L’association du chlorhydrate de chitosan et du GME montre de très bonnes performances in planta contre le mildiou de la laitue. Other in planta tests (GME 1900 mg/L, chitosan hydrochloride 0.05%) showed a synergy ratio of the order of 2.5. The combination of chitosan hydrochloride and GME shows very good in planta performance against lettuce downy mildew.
Exemple 10. Synergie entre un extrait de G. mangostana (GME) et les phosphonates de potassium - essais in vitro sur Plasmopara viticola (mildiou de la vigne) Example 10. Synergy between a G. mangostana extract (GME) and potassium phosphonates - in vitro tests on Plasmopara viticola (vine mildew)
En utilisant le GME (1 ,5 et 2 mg/L) et du chlorhydrate de chitosan (solution à 11 ,5%) à 0,0002% et 0,0004%, on a observé un ratio de synergie compris entre 1 ,2 et 1 ,3. Using GME (1.5 and 2 mg/L) and chitosan hydrochloride (11.5% solution) at 0.0002% and 0.0004%, a synergism ratio between 1.2 and 1.3 was observed.
Exemple 11. Conclusion Example 11. Conclusion
Les essais ci-dessus montrent un effet de l’utilisation combinée d’un extrait de G. mangostana (contenant de la y-mangoustine) et de phosphonates sur divers pathogènes, selon différents protocoles in planta. Ces essais ont permis de mettre en évidence un effet synergique entre le GME et les phosphonates de potassium. Les essais ci-dessus montrent également un effet de l’utilisation combinée d’un extrait de G. mangostana (contenant de la y-mangoustine) et de chitosan sur divers pathogènes, selon différents protocoles in planta, in vitro). Ces essais ont permis de mettre en évidence un effet synergique entre le GME et le chitosan. The above trials show an effect of the combined use of an extract of G. mangostana (containing y-mangostin) and phosphonates on various pathogens, according to different in planta protocols. These trials have demonstrated a synergistic effect between GME and potassium phosphonates. The above trials also show an effect of the combined use of an extract of G. mangostana (containing y-mangostin) and chitosan on various pathogens, according to different in planta, in vitro protocols. These trials have demonstrated a synergistic effect between GME and chitosan.
Ainsi, de façon surprenante, l’ajout de GME dans un produit à base de phosphonates ou de chitosan permet d’augmenter son efficacité (effet synergique) et ainsi possiblement d’en réduire les doses appliquées. Thus, surprisingly, the addition of GME to a product based on phosphonates or chitosan makes it possible to increase its effectiveness (synergistic effect) and thus possibly reduce the doses applied.
Claims
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP24730927.1A EP4719060A1 (en) | 2023-05-30 | 2024-05-29 | Plant treatment method |
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR2305378A FR3149167A1 (en) | 2023-05-30 | 2023-05-30 | Method of processing plants |
| FR2305377A FR3149166A1 (en) | 2023-05-30 | 2023-05-30 | Method of processing plants |
| FRFR2305377 | 2023-05-30 | ||
| FRFR2305378 | 2023-05-30 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| WO2024246169A1 true WO2024246169A1 (en) | 2024-12-05 |
Family
ID=91376863
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PCT/EP2024/064846 Ceased WO2024246169A1 (en) | 2023-05-30 | 2024-05-29 | Plant treatment method |
Country Status (2)
| Country | Link |
|---|---|
| EP (1) | EP4719060A1 (en) |
| WO (1) | WO2024246169A1 (en) |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2023099609A1 (en) | 2021-11-30 | 2023-06-08 | Institut National De Recherche Pour L'agriculture, L'alimentation Et L'environnement (Inrae) | Compositions and methods for controlling phytopathogenic infections |
-
2024
- 2024-05-29 WO PCT/EP2024/064846 patent/WO2024246169A1/en not_active Ceased
- 2024-05-29 EP EP24730927.1A patent/EP4719060A1/en active Pending
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2023099609A1 (en) | 2021-11-30 | 2023-06-08 | Institut National De Recherche Pour L'agriculture, L'alimentation Et L'environnement (Inrae) | Compositions and methods for controlling phytopathogenic infections |
Non-Patent Citations (10)
| Title |
|---|
| ADAMU BIRUK FENTAHUN ET AL: "A review of medicinal plant-based bioactive electrospun nano fibrous wound dressings", MATERIALS & DESIGN, ELSEVIER, AMSTERDAM, NL, vol. 209, 29 June 2021 (2021-06-29), XP086796192, ISSN: 0264-1275, [retrieved on 20210629], DOI: 10.1016/J.MATDES.2021.109942 * |
| ADAMU ET AL., MATERIALS & DESIGN, vol. 209, 2021, pages 109942 |
| AZMAN ET AL., FOOD CONTROL, vol. 141, 2022, pages 109189 |
| AZMAN N H ET AL: "A comprehensive review on biocompatible film sensor containing natural extract: Active/intelligent food packaging", FOOD CONTROL, BUTTERWORTH, LONDON, GB, vol. 141, 16 June 2022 (2022-06-16), XP087115262, ISSN: 0956-7135, [retrieved on 20220616], DOI: 10.1016/J.FOODCONT.2022.109189 * |
| CHARERNSRIWILAIMAT ET AL., INT J PHARM., vol. 452, no. 1-2, 16 August 2013 (2013-08-16), pages 333 - 43 |
| CHARERNSRIWILAIWAT NATTHAN ET AL: "Electrospun chitosan-based nanofiber mats loaded withGarcinia mangostanaextracts", INTERNATIONAL JOURNAL OF PHARMACEUTICS, ELSEVIER, NL, vol. 452, no. 1, 13 May 2013 (2013-05-13), pages 333 - 343, XP028573235, ISSN: 0378-5173, DOI: 10.1016/J.IJPHARM.2013.05.012 * |
| GOPALAKRISHNAN GEETHA ET AL: "Evaluation of the Antifungal Activity of Natural Xanthones from Garcinia mangostana and Their Synthetic Derivatives", JOURNAL OF NATURAL PRODUCTS, vol. 60, no. 5, 1 May 1997 (1997-05-01), US, pages 519 - 524, XP093100561, ISSN: 0163-3864, DOI: 10.1021/np970165u * |
| J NAT PROD., vol. 60, no. 5, May 1997 (1997-05-01), pages 519 - 24 |
| SAMPRASIT ET AL., CARBOHYDR POLYM., vol. 117, 6 March 2015 (2015-03-06), pages 933 - 940 |
| SAMPRASIT WIPADA ET AL: "Mucoadhesive electrospun chitosan-based nanofibre mats for dental caries prevention", CARBOHYDRATE POLYMERS, APPLIED SCIENCE PUBLISHERS , LTD BARKING, GB, vol. 117, 23 October 2014 (2014-10-23), pages 933 - 940, XP029113709, ISSN: 0144-8617, DOI: 10.1016/J.CARBPOL.2014.10.026 * |
Also Published As
| Publication number | Publication date |
|---|---|
| EP4719060A1 (en) | 2026-04-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2018234690A1 (en) | USE OF ROQUETTE PLANT PART EXTRACT FOR STIMULATING PLANT AND TREE DEFENSE AND COMPOSITION AND METHOD THEREOF | |
| Mouna et al. | Insecticidal effect of two aqueous extracts from the leaves of Salvia officinalis and Eucalyptus camaldulensis against Aphis fabae | |
| WO2020109729A1 (en) | New composition for protecting plants from pathogens | |
| EP1631148B1 (en) | Elicitor made from trigonella foenum graecum extracts for the treatment of plant pathogens, use thereof, and method for the production thereof | |
| US20170238546A1 (en) | Novel plant functional activated nano vacc-fertiliceutical, and methods of preparation, formulation, dilution, and use thereof | |
| CA3071563A1 (en) | Therapeutic or non-therapeutic use of protozoans of the willaertia genus as a fungistatic and/or fungicide | |
| JPH09508899A (en) | Trichoderma and metabolites as biological control agents | |
| WO2024246169A1 (en) | Plant treatment method | |
| FR3149167A1 (en) | Method of processing plants | |
| FR3149166A1 (en) | Method of processing plants | |
| EP2587924B1 (en) | Use of a natural grape marc extract in order to stimulate the natural defenses of plants | |
| Mohammed et al. | Some biochemical changes in Eobania vermiculata snail treated with some plant extracts under laboratory conditions | |
| CA2450878A1 (en) | Elicitor made from trigonella foenum graecum seed extracts and use thereof in controlling pathogenic organisms of plants | |
| FR3145464A1 (en) | Method of processing plants | |
| FR3031005B1 (en) | FUNGICIDE IN THE FORM OF BIOLOGICAL AND ECOLOGICAL SOLUTION FOR PLANT GROWTH | |
| CA3170942A1 (en) | Phytosanitary composition comprising ulvans and silicon | |
| EP3621440B1 (en) | Use of an extract of part of a rocket plant for stimulating the defenses of plants and trees and associated composition and method | |
| EP4561356A1 (en) | Sprayable antifungal composition for use in the field of agriculture, and associated method and use | |
| EP4489575A1 (en) | Phytosanitary composition and use thereof | |
| EP4573907A1 (en) | Butyric acid, butyric acid salt or butyric acid derivative for stimulating and/or inhibiting the immune responses of plants and/or treating plant infections | |
| EP4152931A1 (en) | Use of 4-phenylbutyric acid and/or 3-phenylbutyric acid and/or 2-phenylbutyric acid in preventing and treating cryptogamic diseases | |
| CA2946959A1 (en) | Use of alcohol(s) as fungicide and/or algicide | |
| EP4568487A1 (en) | Biocontrol product using a co-product of leek | |
| EP3905884A1 (en) | Natural herbicide | |
| FR3019970A1 (en) | PHYTOSANITARY COMPOSITION AND METHOD FOR CURATIVE AND / OR PREVENTIVE TREATMENT OF A PLANT, IN PARTICULAR VINE, EMPLOYING THE COMPOSITION |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 24730927 Country of ref document: EP Kind code of ref document: A1 |
|
| NENP | Non-entry into the national phase |
Ref country code: DE |
|
| WWE | Wipo information: entry into national phase |
Ref document number: 2024730927 Country of ref document: EP |
|
| ENP | Entry into the national phase |
Ref document number: 2024730927 Country of ref document: EP Effective date: 20260102 |
|
| ENP | Entry into the national phase |
Ref document number: 2024730927 Country of ref document: EP Effective date: 20260102 |
|
| ENP | Entry into the national phase |
Ref document number: 2024730927 Country of ref document: EP Effective date: 20260102 |
|
| ENP | Entry into the national phase |
Ref document number: 2024730927 Country of ref document: EP Effective date: 20260102 |
|
| ENP | Entry into the national phase |
Ref document number: 2024730927 Country of ref document: EP Effective date: 20260102 |
|
| ENP | Entry into the national phase |
Ref document number: 2024730927 Country of ref document: EP Effective date: 20260102 |
|
| WWP | Wipo information: published in national office |
Ref document number: 2024730927 Country of ref document: EP |








